≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Background retinopathy and retinal vascular changes

DOID EFO Endpoint Browser PheWeb

H7_BCKRNDRETINOPAT

age-related macular degeneration: Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H35.0
  • Hospital discharge: ICD-9 — 3621|3624A
  • Hospital discharge: ICD-8 — 36701|37705|37709|37712
  • Cause of death: ICD-10 — H35.0
  • Cause of death: ICD-9 — 3621|3624A
  • Cause of death: ICD-8 — 36701|37705|37709|37712

2 out of 7 registries used, show all original rules.

844

4. Check minimum number of events

None

844

5. Include endpoints

None

844

6. Filter based on genotype QC (FinnGen only)

810

Control definitions (FinnGen only)

Control exclude
H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF6
Parent code in ICD-10
H35
Name in latin
Retinopathia recessualis et commutationes vasculares retinae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6024 2953 3018
Only index persons 5178 2570 2608
Unadjusted period prevalence (%)
Whole population 0.08 0.08 0.08
Only index persons 0.10 0.09 0.10
Median age at first event (years)
Whole population 59.07 63.57 54.72
Only index persons 58.11 62.71 53.57

-FinnGen-

Key figures

All Female Male
Number of individuals 810 388 422
Unadjusted period prevalence (%) 0.17 0.14 0.19
Median age at first event (years) 59.10 59.71 58.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
844
Matched controls
8440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
4503599627370496.0
307.7
747
*
XCK10
NOMESCO Finland
Photography of fundus of eye
13.8
261.1
291
311
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
20.2
259.0
217
142
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
14.8
246.7
254
239
XCW99
NOMESCO Finland
Other investigative procedure of eye
12.1
213.8
252
287
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
277.3
195.6
193
9
H43.1
ICD-10 Finland
Vitreous haemorrhage
44.1
195.2
118
31
CKC12
NOMESCO Finland
Photocoagulation of retina
330.7
186.0
182
7
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
39.8
183.7
114
33
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
42.0
180.0
110
30
A10AA02, ,
ATC
20.7
166.4
132
75
A10AB01
ATC
insulin (human); parenteral
20.7
159.3
126
71
A10AC01
ATC
insulin (human); parenteral
9.3
151.9
211
291
A10AA01, ,
ATC
26.8
150.5
106
45
T89
ICPC
Diabetes insulin dependent
15.9
149.3
136
101
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
34.3
142.6
92
30
Z01.0
ICD-10 Finland
Examination of eyes and vision
6.2
136.7
323
772
A10AB04
ATC
insulin lispro; parenteral
18.6
130.8
108
66
A10AE04
ATC
insulin glargine; parenteral
7.3
127.8
226
405
A10AB05
ATC
insulin aspart; parenteral
8.3
127.3
192
289
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
14.4
125.7
120
96
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
16.9
118.9
103
69
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
228.2
116.9
118
6
XCH00
NOMESCO Finland
Eye pressure measurement
10.9
109.3
126
134
H04AA01
ATC
glucagon; nasal, parenteral
26.0
107.6
76
32
XCD20
NOMESCO Finland
Photoangiography of eye
208.2
107.2
109
6
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
26.5
106.9
75
31
A10AE05
ATC
insulin detemir; parenteral
9.1
106.9
143
185
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
158.1
94.3
98
7
WX140
NOMESCO Finland
Parabulbar anesthesy
14.3
93.5
88
68
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.8
91.8
139
207
CKC10
NOMESCO Finland
Local photocoagulation of retina
493.5
91.1
89
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.0
89.7
245
640
H36.01
ICD-10 Finland
Diabetic maculopathy
328.8
88.5
88
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
38.7
82.3
51
14
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
12.7
79.3
80
69
H34.8
ICD-10 Finland
Other retinal vascular occlusions
419.6
78.2
77
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
12.2
78.1
81
73
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
808.1
76.5
74
*
H3601, E113,
ICD-10 Finland
+∞
76.2
72
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.7
76.1
390
1582
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
43.2
74.7
45
11
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.7
72.5
347
1339
Z94.0
ICD-10 Finland
Kidney transplant status
22.1
72.2
54
26
H36.00
ICD-10 Finland
Diabetic background retinopathy
736.6
70.1
68
*
A10AE06
ATC
insulin degludec; parenteral
9.2
69.8
89
107
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
22.1
69.5
52
25
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
12.2
69.0
71
63
H3603, E103,
ICD-10 Finland
+∞
64.4
61
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.6
61.8
43
17
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
23.2
60.0
44
20
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
18.8
59.8
48
27
127
Kela drug reimbursment
Transplant complication
14.3
59.3
55
41
E10
ICD-10 Finland
Type 1 diabetes mellitus
18.4
57.9
47
27
A11CC03
ATC
alfacalcidol; systemic
9.1
56.5
72
86
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.0
55.6
133
304
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
19.6
54.7
43
23
H33.0
ICD-10 Finland
Retinal detachment with retinal break
562.5
54.2
53
*
A10AD01
ATC
insulin (human); parenteral
14.4
53.2
49
36
A12AA04
ATC
calcium carbonate; oral
12.2
52.9
54
47
137
Kela drug reimbursment
Uraemia requiring dialysis
20.9
52.4
40
20
H3600, E103,
ICD-10 Finland
+∞
51.6
49
*
XCK00
NOMESCO Finland
Perimetry
5.6
50.8
103
203
Z3229
NOMESCO Finland
Other healthcare associate professional
4.5
49.5
137
351
CKC15
NOMESCO Finland
Panretinal photocoagulation
138.3
49.4
52
*
L04AA06
ATC
mycophenolic acid; systemic
10.8
48.9
54
53
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.9
48.0
384
1907
H3603, E113,
ICD-10 Finland
+∞
47.3
45
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
15.9
47.1
41
27
TK800
NOMESCO Finland
Hemodialysis
8.8
46.3
60
73
L04AD02
ATC
tacrolimus; systemic
16.3
45.4
39
25
H3600, E113,
ICD-10 Finland
+∞
45.2
43
*
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
17.5
44.7
37
22
N18.0
ICD-10 Finland
End-stage renal disease
14.9
44.5
40
28
H3601, E103,
ICD-10 Finland
+∞
44.1
42
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
12.5
44.0
44
37
S01EC01
ATC
acetazolamide; systemic
9.5
43.8
53
59
N18.8
ICD-10 Finland
Other chronic renal failure
8.7
43.6
57
70
XCW10
NOMESCO Finland
Assessment of vision
14.4
43.6
40
29
S01BC03
ATC
diclofenac; ophthalmic
9.5
42.0
51
57
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
9.5
42.0
51
57
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.7
41.3
374
1943
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
220.7
41.2
42
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
10.5
41.0
46
46
H26.4
ICD-10 Finland
After-cataract
3.8
40.7
141
423
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.6
40.6
53
65
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
79.3
40.3
45
6
ZXA10
NOMESCO Finland
Bilateral
3.0
40.1
222
890
CKD40
NOMESCO Finland
Endophotocoagulation of retina
405.5
39.4
39
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
11.3
38.5
41
38
B03XA02
ATC
darbepoetin alfa; parenteral
8.2
38.2
52
67
V03AE01
ATC
polystyrene sulfonate; oral
11.0
37.8
41
39
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
13.4
37.6
36
28
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
136.1
37.0
39
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
51.4
37.0
44
9
H33.3
ICD-10 Finland
Retinal breaks without detachment
372.5
36.3
36
*
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
193.2
36.1
37
*
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
8.0
36.0
50
66
H35.8
ICD-10 Finland
Other specified retinal disorders
+∞
35.7
34
*
H35.6
ICD-10 Finland
Retinal haemorrhage
+∞
35.7
34
*
C03CA01
ATC
furosemide; systemic
2.5
35.6
370
2018
C02AC05
ATC
moxonidine; oral
4.5
34.2
88
211
205
Kela drug reimbursment
Chronic hypertension
2.5
34.0
320
1661
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
36.7
33.1
42
12
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.8
32.9
110
320
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
+∞
32.5
31
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.1
31.2
69
146
SPAT1262
SPAT
Handing over of treatment supplies
2.7
30.9
202
874
H35.7
ICD-10 Finland
Separation of retinal layers
+∞
30.4
29
*
C08CA01
ATC
amlodipine; oral
2.3
30.4
408
2444
C09AA02
ATC
enalapril; systemic
2.6
30.3
238
1125
H25.1
ICD-10 Finland
Senile nuclear cataract
2.4
30.1
304
1612
I10
ICD-10 Finland
Essential (primary) hypertension
2.4
30.0
602
4262
S01ED51
ATC
timolol, combinations; ophthalmic
3.7
29.7
101
297
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.4
29.6
61
121
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
40.5
28.2
35
9
T90
ICPC
Diabetes non-insulin dependent
2.4
28.0
264
1351
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
+∞
27.2
26
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
27.0
278
1474
H3603, E106,
ICD-10 Finland
+∞
26.2
25
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
62.1
26.1
30
5
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
32.1
26.1
34
11
H3601, H350,
ICD-10 Finland
+∞
25.1
24
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.8
24.5
140
560
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
32.1
23.8
31
10
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
246.7
23.8
24
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
128.7
23.7
25
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
55.7
23.2
27
5
H35.36
ICD-10 Finland
Macular cyst
+∞
23.0
22
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
22.6
462
3138
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
28.2
22.4
30
11
H43.8
ICD-10 Finland
Other disorders of vitreous body
3.0
22.2
105
378
B01AC04
ATC
clopidogrel; oral
2.3
22.1
197
970
H25.8
ICD-10 Finland
Other senile cataract
2.8
22.1
127
508
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
22.0
388
2492
H35.9
ICD-10 Finland
Retinal disorder, unspecified
64.3
22.0
25
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
22.9
21.8
31
14
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
225.6
21.7
22
*
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
118.1
21.7
23
*
B05DA
ATC
Isotonic solutions
19.5
21.4
32
17
B05DB
ATC
Hypertonic solutions
21.4
21.4
31
15
CKC20
NOMESCO Finland
Cryopexy of undetached retina
215.1
20.7
21
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
20.7
80
255
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
33.5
20.3
26
8
C10AA01
ATC
simvastatin; oral
2.0
20.3
406
2703
C10AA05
ATC
atorvastatin; oral
2.0
20.2
404
2687
V03AE02
ATC
sevelamer; oral
27.8
20.1
27
10
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.6
20.1
135
583
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
20.0
257
1461
H3601, E116,
ICD-10 Finland
+∞
19.9
19
*
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
75.3
19.8
22
*
H26.02
ICD-10 Finland
Presenil cataract
5.2
19.7
41
82
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
22.2
19.6
28
13
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
19.6
143
642
Z3231
NOMESCO Finland
Registered nurse
2.1
19.4
259
1490
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.2
19.2
52
129
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.1
19.2
249
1416
C07AB07
ATC
bisoprolol; oral
1.9
19.2
469
3316
WX002
NOMESCO Finland
Sedation and analgesia
2.2
19.1
186
945
J01FF01
ATC
clindamycin; systemic
2.1
19.1
254
1457
OAB50, ,
SPAT
2.9
19.0
98
369
Z49.2
ICD-10 Finland
Other dialysis
17.6
18.8
29
17
A10AD05
ATC
insulin aspart; parenteral
5.8
18.8
35
63
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
71.6
18.8
21
*
ZXA00
NOMESCO Finland
Right side
2.0
18.6
255
1477
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.1
18.6
53
137
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.6
18.3
114
474
A10BB01
ATC
glibenclamide; oral
3.7
18.2
59
167
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
17.8
239
1370
196
Kela drug reimbursment
Paricalcitol and cinacalcet
23.4
17.8
25
11
CKD15
NOMESCO Finland
Injection of vitreous substitute
+∞
17.8
17
*
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
4.7
17.7
41
90
S01ED01
ATC
timolol; ophthalmic
4.1
17.7
49
124
H35.37
ICD-10 Finland
Macular holes
183.7
17.6
18
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
19.1
17.4
26
14
H26.2
ICD-10 Finland
Complicated cataract
16.4
17.1
27
17
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
32.2
17.1
22
7
A10BA02
ATC
metformin; oral
1.9
16.8
280
1727
H3603, H350,
ICD-10 Finland
+∞
16.7
16
*
S01EA05
ATC
brimonidine; ophthalmic
4.8
16.7
38
82
NHQ40
NOMESCO Finland
Amputation of toe
5.7
16.6
31
56
C08CA13
ATC
lercanidipine; oral
2.2
16.2
153
765
H20.1
ICD-10 Finland
Chronic iridocyclitis
17.1
16.2
25
15
C08CA02
ATC
felodipine; oral
2.5
16.1
111
483
V03AE03
ATC
lanthanum carbonate; oral
25.0
16.1
22
9
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
16.0
90
354
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
16.0
181
971
ZXA05
NOMESCO Finland
Left side
2.0
15.9
230
1347
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.3
15.8
62
199
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
15.8
131
620
36701
ICD-8 Finland
Inflammation of optic nerve and retina, Periphlebitis retinae
+∞
15.7
15
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
15.6
75
271
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
162.9
15.5
16
*
S01EC03
ATC
dorzolamide; ophthalmic
6.2
15.2
26
43
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.2
15.1
41
102
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
45.9
15.1
18
*
C10AX09
ATC
ezetimibe; oral
2.1
15.1
164
865
H02AB04
ATC
methylprednisolone; systemic
2.2
15.0
142
709
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.6
15.0
24
37
A10BB12
ATC
glimepiride; oral
2.7
14.9
85
337
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
11.6
14.8
27
24
37709
ICD-8 Finland
Other diseases of retina and optic nerve, Laesio vascularis retinae NUD
+∞
14.6
14
*
CKD20
NOMESCO Finland
Removal of vitreous body substitute
+∞
14.6
14
*
H35.4
ICD-10 Finland
Peripheral retinal degeneration
81.6
14.6
16
*
S01EE01
ATC
latanoprost; ophthalmic
2.9
14.5
71
259
ZX120
NOMESCO Finland
Intravenous
2.5
14.3
98
425
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.3
14.3
24
39
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
14.3
37
89
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.5
14.0
49
146
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
13.8
165
898
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
10.7
13.8
26
25
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.9
13.7
40
105
S97
ICPC
Chronic ulcer skin
2.7
13.7
74
285
H33.4
ICD-10 Finland
Traction detachment of retina
+∞
13.6
13
*
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
+∞
13.6
13
*
H3601, E106,
ICD-10 Finland
+∞
13.6
13
*
1LA05, ,
NOMESCO Finland
+∞
13.6
13
*
CK9G4
NOMESCO Finland
Iridocyanine green angiography (ICGA) of choroid and retina
+∞
13.6
13
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
16.5
13.5
21
13
H34.2
ICD-10 Finland
Other retinal artery occlusions
142.2
13.5
14
*
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
142.2
13.5
14
*
S01EC04
ATC
brinzolamide; ophthalmic
3.5
13.5
47
140
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.3
13.3
35
85
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
28.9
13.0
17
6
L28
ICPC
Limited function/disability (L)
1.9
12.9
188
1094
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.8
12.8
239
1505
114
Kela drug reimbursment
Glaucoma
2.4
12.8
90
394
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
32.6
12.6
16
5
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
17.6
12.6
19
11
CK2K4
NOMESCO Finland
Red-free imaging of ocular fundus
+∞
12.5
12
*
H3602, E103,
ICD-10 Finland
+∞
12.5
12
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
12.5
184
1074
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
12.4
318
2192
H40.0
ICD-10 Finland
Glaucoma suspect
2.5
12.4
79
331
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
4.3
12.3
32
77
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
12.3
203
1229
B03XA01
ATC
erythropoietin; parenteral
10.7
12.3
23
22
C01DA14
ATC
isosorbide mononitrate; oral
2.0
12.3
166
941
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.4
12.3
31
73
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.0
12.2
56
197
C02CA01
ATC
prazosin; oral
5.0
12.2
26
53
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
12.2
223
1394
C09CA06
ATC
candesartan; oral
1.8
12.1
211
1299
SPAT1254
SPAT
Administration of medicine
2.0
11.9
139
748
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
11.9
163
928
ZX198
NOMESCO Finland
Other local administration
11.9
11.9
21
18
H05BX01
ATC
cinacalcet; oral
11.9
11.9
21
18
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
6.0
11.8
21
36
S01EA03
ATC
apraclonidine; ophthalmic
10.7
11.8
22
21
L04AD01
ATC
ciclosporin; systemic
5.2
11.8
24
47
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
11.8
114
572
TK820
NOMESCO Finland
Peritoneal dialysis
16.7
11.7
18
11
R4120
NOMESCO Finland
Occupational therapy
2.6
11.7
68
272
A10AA03, ,
ATC
12.8
11.7
20
16
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
11.5
60
227
H34.9
ICD-10 Finland
Retinal vascular occlusion, unspecified
+∞
11.5
11
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
+∞
11.5
11
*
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
+∞
11.5
11
*
J01DB01
ATC
cefalexin; oral
1.9
11.5
680
5823
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
11.5
118
606
H25.0
ICD-10 Finland
Senile incipient cataract
2.7
11.3
63
247
J01MA02
ATC
ciprofloxacin; systemic
1.7
11.2
337
2407
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.5
11.2
72
302
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
11.2
190
1157
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
11.0
128
687
AA1AD
NOMESCO Finland
CT of head and brain
1.7
11.0
263
1768
E87.5
ICD-10 Finland
Hyperkalaemia
4.2
10.9
29
71
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.8
253
1688
S01BC05
ATC
ketorolac; ophthalmic
3.1
10.7
46
156
H53.4
ICD-10 Finland
Visual field defects
4.2
10.7
28
68
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
10.7
63
254
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
4.0
10.6
30
77
L04AA01
ATC
[U] ciclosporin
8.1
10.6
23
29
H360, E103,
ICD-10 Finland
+∞
10.4
10
*
H34.1
ICD-10 Finland
Central retinal artery occlusion
+∞
10.4
10
*
H35.29
ICD-10 Finland
Other proliferative retinopathy
+∞
10.4
10
*
C09CA01
ATC
losartan; oral
1.7
10.4
228
1494
RS221, ,
NOMESCO Finland
5.2
10.4
21
41
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
10.3
161
953
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
10.8
10.3
19
18
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
5.0
10.3
22
45
A10BK01
ATC
dapagliflozin; oral
2.3
10.1
77
349
R06.0
ICD-10 Finland
Dyspnoea
1.7
10.1
245
1646
A10BH01
ATC
sitagliptin; oral
2.2
10.1
90
437
SPAT1301
SPAT
No procedures
1.7
10.1
256
1742
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
40.6
10.0
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.0
189
1186
C08CA10
ATC
nilvadipine; oral
4.3
9.9
25
59
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
26.4
9.8
13
5
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
26.4
9.8
13
5
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
20.3
9.8
14
7
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
20.3
9.8
14
7
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.8
9.8
22
47
BEF00, ,
SPAT
9.7
9.8
19
20
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.8
289
2040
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.5
9.8
63
265
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
9.8
71
316
R4190
NOMESCO Finland
Nutritional therapy
3.0
9.7
42
143
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
13.6
9.7
16
12
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.4
9.7
66
285
WZC30
NOMESCO Finland
Teaching
1.9
9.7
144
839
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
55.6
9.7
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
9.6
128
719
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
9.6
50
189
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
9.6
118
645
H16.0
ICD-10 Finland
Corneal ulcer
2.7
9.6
53
207
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
9.2
9.6
19
21
G63.2
ICD-10 Finland
Diabetic polyneuropathy
15.2
9.5
15
10
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
9.5
99
510
J01MA12
ATC
levofloxacin; systemic
1.8
9.5
167
1025
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
101.1
9.4
10
*
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
101.1
9.4
10
*
171
Kela drug reimbursment
Degludekinsuliini
30.4
9.4
12
*
L04AX01
ATC
azathioprine; systemic
3.0
9.4
42
146
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
5.2
9.4
19
37
37712
ICD-8 Finland
Other diseases of retina and optic nerve, Retinitis exsudativa externa (Coats)
+∞
9.4
9
*
3624A
ICD-9 Finland
Other retinal disorders, Separation of retinal layers[RETINOPATHIA CENTRALIS SEROSA]
+∞
9.4
9
*
H33.2
ICD-10 Finland
Serous retinal detachment
+∞
9.4
9
*
CKC30
NOMESCO Finland
Cryopexy of detached retina
+∞
9.4
9
*
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
+∞
9.4
9
*
3621A
ICD-9 Finland
Other retinal disorders, Other background retinopathy and retinal vascular changes
+∞
9.4
9
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.8
9.4
28
75
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
5.0
9.3
20
41
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
9.3
59
246
321
Kela drug reimbursment
Paricalcitol and cinacalcet
9.7
9.3
18
19
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.9
9.2
43
153
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
9.2
80
384
A46
ICD-10 Finland
Erysipelas
1.9
9.2
137
798
C09AA05
ATC
ramipril; oral
1.7
9.2
229
1545
CS494
NOMESCO Finland
Other visual field testing
3.7
9.2
29
81
WX872
NOMESCO Finland
Intensive care
2.6
9.1
55
224
N19
ICD-10 Finland
Unspecified kidney failure
2.8
9.1
46
171
H02AB06
ATC
prednisolone; systemic
1.6
9.1
391
3002
I50.0
ICD-10 Finland
Congestive heart failure
2.2
9.1
83
406
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
24.3
8.9
12
5
RD210, ,
NOMESCO Finland
4.7
8.9
20
43
S18
ICPC
Laceration/cut
1.6
8.8
384
2952
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
8.8
62
272
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
8.8
279
1995
A02BC02
ATC
pantoprazole; systemic
1.6
8.7
556
4645
Z71.8
ICD-10 Finland
Other specified counselling
1.6
8.7
262
1847
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.3
8.7
22
52
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.7
8.7
179
1146
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
8.6
80
394
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
8.6
134
790
R60.0
ICD-10 Finland
Localized oedema
1.9
8.6
111
616
ZXE00
NOMESCO Finland
One hour or less
1.6
8.6
305
2236
U14
ICPC
Kidney symptom/complaint
4.1
8.6
23
57
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
8.6
112
625
A12AA12
ATC
[U] calcium acetate
27.8
8.5
11
*
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.7
8.5
45
172
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.6
8.5
49
196
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
90.9
8.4
9
*
H3603, E107,
ICD-10 Finland
+∞
8.3
8
*
H360, E113,
ICD-10 Finland
+∞
8.3
8
*
H3601, E118,
ICD-10 Finland
+∞
8.3
8
*
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
8.3
8
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
8.3
251
1769
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
8.3
142
862
WX199
NOMESCO Finland
Other local analgesia
3.0
8.2
36
124
A10AB06
ATC
insulin glulisine; parenteral
7.6
8.2
18
24
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
8.2
53
224
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.1
8.1
34
114
Z96.4
ICD-10 Finland
Presence of endocrine implants
33.7
8.1
10
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
8.1
140
852
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.4
8.1
55
238
J01MA14
ATC
moxifloxacin; systemic
2.1
8.0
83
426
L17
ICPC
Foot/toe symptom/complaint
1.6
8.0
243
1711
XF402
NOMESCO Finland
ECG with work load test
2.0
8.0
95
512
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
8.0
230
1600
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
7.3
8.0
18
25
WX202
NOMESCO Finland
Supraclavicular plexus blockade
4.3
8.0
20
47
N03AX16
ATC
[U] pregabalin
1.7
7.9
187
1241
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
3.1
7.8
33
111
TK810
NOMESCO Finland
Hemofiltration
8.6
7.8
16
19
3025
Kela drug reimbursment
Calcium carbonate
9.5
7.8
15
16
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
7.8
217
1497
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
6.5
7.7
19
30
N02AX02
ATC
tramadol; systemic, rectal
1.5
7.7
355
2738
C07AB02
ATC
metoprolol; systemic
1.7
7.7
176
1155
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
7.7
57
256
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
7.7
186
1239
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
4.0
7.6
21
53
N02BE01
ATC
paracetamol; systemic, rectal
1.8
7.6
729
6589
H57.1
ICD-10 Finland
Ocular pain
2.9
7.6
35
124
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
7.6
89
479
SPAT1325
SPAT
Vaccination
1.5
7.5
261
1892
H16.9
ICD-10 Finland
Keratitis, unspecified
4.3
7.5
19
45
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.5
7.4
25
73
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.4
7.4
26
78
D31.2
ICD-10 Finland
Benign neoplasm: Retina
80.8
7.4
8
*
C09BA02
ATC
enalapril and diuretics; systemic
2.1
7.4
74
375
WX892
NOMESCO Finland
Monitored bed care
2.1
7.4
75
382
K65.0
ICD-10 Finland
Acute peritonitis
6.0
7.4
19
32
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.2
7.3
63
301
Z2221
NOMESCO Finland
Medical doctor
1.6
7.3
211
1464
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
7.3
56
255
B80
ICPC
Iron deficiency anaemia
3.2
7.3
28
89
SPAT1263
SPAT
Sampling
1.5
7.3
319
2426
H3603, E116,
ICD-10 Finland
+∞
7.3
7
*
H3602, E113,
ICD-10 Finland
+∞
7.3
7
*
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
7.3
7
*
QDH
NOMESCO Finland
Operations on toe nails
+∞
7.3
7
*
H3601, E119,
ICD-10 Finland
+∞
7.3
7
*
A41.8
ICD-10 Finland
Other specified sepsis
3.5
7.3
25
74
A28
ICPC
Limited function/disability NOS
1.7
7.3
163
1064
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.8
7.2
36
134
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
20.2
7.1
10
5
C07AG02
ATC
carvedilol; oral
2.2
7.1
62
298
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.1
92
511
S91.3
ICD-10 Finland
Open wound of other parts of foot
3.1
7.1
29
96
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
7.1
80
424
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
12.2
7.1
12
10
R80
ICD-10 Finland
Isolated proteinuria
12.2
7.1
12
10
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
12.2
7.1
12
10
Z2446
NOMESCO Finland
Social worker
2.2
7.1
59
279
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
10.1
7.0
13
13
F01
ICPC
Eye pain
3.0
7.0
30
102
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
7.0
71
362
S01BA07
ATC
fluorometholone; ophthalmic
5.5
6.9
19
35
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.8
6.9
34
125
I21.4
ICD-10 Finland
Acute subendocardial myocardial infarction
4.0
6.9
19
48
K08.3
ICD-10 Finland
Retained dental root
2.1
6.9
69
350
M86.6
ICD-10 Finland
Other chronic osteomyelitis
13.9
6.9
11
8
WX142
NOMESCO Finland
Sub-tenon anesthesy
13.9
6.9
11
8
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.8
543
4628
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
6.8
28
93
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.2
6.8
59
284
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.7
233
1684
H18.2
ICD-10 Finland
Other corneal oedema
22.7
6.7
9
*
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.1
6.7
62
306
SPAT1097
SPAT
Recording of ECG
1.7
6.6
119
730
S01EC54
ATC
brinzolamide, combinations; ophthalmic
6.0
6.6
17
29
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
6.6
235
1705
S01FA01
ATC
atropine; ophthalmic
12.4
6.6
11
9
3AC01, ,
NOMESCO Finland
6.9
6.5
15
22
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
6.3
6.5
16
26
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
6.5
91
519
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
3.2
6.5
25
80
B07.9
ICD-10 Finland
Verruca simplex
2.7
6.5
33
124
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
6.4
58
283
3643
FHL
Vitrectomy through pars Plana
70.4
6.4
7
*
N08.3
ICD-10 Finland
Glomerular disorders in diabetes mellitus
70.4
6.4
7
*
A10BK03
ATC
empagliflozin; oral
1.8
6.4
90
513
AN1
HP
Coronary angiography
1.8
6.4
100
590
QDB10, ,
SPAT
2.8
6.4
30
108
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.4
6.4
27
685
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
6.3
63
319
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.8
6.3
31
114
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
6.3
109
661
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
6.3
49
225
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
11.1
6.3
11
10
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.3
229
1667
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
6.3
98
577
S29
ICPC
Skin symptom/complaint other
1.6
6.3
155
1034
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
18.2
6.3
9
5
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
+∞
6.3
6
*
H3601, H547,
ICD-10 Finland
+∞
6.3
6
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
+∞
6.3
6
*
M14.6
ICD-10 Finland
Neuropathic arthropathy
+∞
6.3
6
*
H30.2
ICD-10 Finland
Posterior cyclitis
+∞
6.3
6
*
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
+∞
6.3
6
*
37700
ICD-8 Finland
Other diseases of retina and optic nerve, Haemorrhagia corporis vitrei
+∞
6.3
6
*
CKC70
NOMESCO Finland
Circular buckling of sclera
+∞
6.3
6
*
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
+∞
6.3
6
*
N083, E102,
ICD-10 Finland
+∞
6.3
6
*
R4110
NOMESCO Finland
Physiotherapy
1.5
6.2
219
1583
K29
ICPC
Cardiovascular sympt/complt other
2.5
6.2
38
157
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
6.2
81
452
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
6.1
62
316
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
6.1
31
116
C03AA03
ATC
hydrochlorothiazide; oral
1.9
6.1
78
431
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.1
6.1
25
83
J01DA01
ATC
[U] cefalexin
1.4
6.1
477
4012
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
6.1
88
506
R4180, ,
SPAT
4.2
6.1
16
39
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
12.6
6.1
10
8
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
6.1
48
222
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
6.1
271
2054
H47.1
ICD-10 Finland
Papilloedema, unspecified
8.7
6.1
12
14
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
8.7
6.1
12
14

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ophthalmology
18 [38004463]
1.7e+00
2.8e+00
3.5e+00
—
4.1e+00
3.9e+00
2.6e+00
cases:42.07%
controls:11.45%
cases:42.07%
controls:4.08%
cases:17.84%
controls:0.67%
—
—
cases:25.12%
controls:0.57%
cases:69.99%
controls:4.68%
cases:65.51%
controls:12.26%
342
927
471
7167
342
330
471
7764
145
54
668
8040
—
204
46
608
8023
548
363
235
7388
435
807
229
5777
Diabetes insulin dependent
T89 [2002001130]
2.8e+00
2.9e+00
2.9e+00
—
2.1e+00
2.4e+00
2.2e+00
cases:5.90%
controls:0.37%
cases:4.80%
controls:0.28%
cases:1.60%
controls:0.09%
—
—
cases:0.74%
controls:0.09%
cases:3.70%
controls:0.35%
cases:6.48%
controls:0.79%
48
30
765
8064
39
23
774
8071
13
7
800
8087
—
6
7
806
8062
29
27
754
7724
43
52
621
6532
Nephrology
39 [38004479]
1.7e+00
2.4e+00
3.1e+00
—
3.1e+00
2.6e+00
2.3e+00
cases:4.06%
controls:0.77%
cases:5.04%
controls:0.46%
cases:3.20%
controls:0.15%
—
—
cases:3.57%
controls:0.17%
cases:6.51%
controls:0.49%
cases:8.43%
controls:0.88%
33
62
780
8032
41
37
772
8057
26
12
787
8082
—
29
14
783
8055
51
38
732
7713
56
58
608
6526
insulin degludec; parenteral
A10AE06 [43534747]
3.0e+00
2.5e+00
2.0e+00
—
2.9e+00
2.4e+00
1.7e+00
cases:4.18%
controls:0.21%
cases:3.81%
controls:0.32%
cases:0.98%
controls:0.14%
—
—
cases:1.35%
controls:0.07%
cases:3.96%
controls:0.39%
cases:2.86%
controls:0.56%
34
17
779
8077
31
26
782
8068
8
11
805
8083
—
11
6
801
8063
31
30
752
7721
19
37
645
6547
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
2.9e+00
3.9e+00
—
1.0e+50
—
3.7e+00
3.2e+00
cases:8.12%
controls:0.48%
cases:6.27%
controls:0.14%
—
—
cases:5.66%
controls:0.00%
—
—
cases:8.68%
controls:0.25%
cases:8.89%
controls:0.38%
66
39
747
8055
51
11
762
8083
—
46
0
767
8094
—
68
19
715
7732
59
25
605
6559
Plain photography of ocular fundus
CK2S4 [2001301455]
3.0e+00
3.3e+00
—
1.0e+50
—
3.9e+00
3.5e+00
cases:4.67%
controls:0.25%
cases:2.95%
controls:0.11%
—
—
cases:2.09%
controls:0.00%
—
—
cases:4.34%
controls:0.09%
cases:6.02%
controls:0.20%
38
20
775
8074
24
9
789
8085
—
17
0
796
8094
—
34
7
749
7744
40
13
624
6571
Examination of eyes and vision
Z01.0 [45566391]
1.8e+00
2.8e+00
4.2e+00
1.0e+50
—
2.9e+00
1.9e+00
cases:8.00%
controls:1.46%
cases:6.40%
controls:0.41%
cases:3.94%
controls:0.06%
cases:2.83%
controls:0.00%
—
—
cases:9.83%
controls:0.58%
cases:10.69%
controls:1.81%
65
118
748
7976
52
33
761
8061
32
5
781
8089
23
0
790
8094
—
77
45
706
7706
71
119
593
6465
insulin lispro; parenteral
A10AB04 [21600718]
2.4e+00
2.1e+00
2.4e+00
—
2.2e+00
2.2e+00
2.1e+00
cases:7.26%
controls:0.68%
cases:5.54%
controls:0.68%
cases:1.72%
controls:0.16%
—
—
cases:1.60%
controls:0.19%
cases:5.75%
controls:0.65%
cases:7.23%
controls:0.96%
59
55
754
8039
45
55
768
8039
14
13
799
8081
—
13
15
799
8054
45
50
738
7701
48
63
616
6521
insulin lispro; parenteral
A10AC04 [21600726]
2.4e+00
2.1e+00
2.4e+00
—
2.2e+00
2.2e+00
2.1e+00
cases:7.26%
controls:0.68%
cases:5.54%
controls:0.68%
cases:1.72%
controls:0.16%
—
—
cases:1.60%
controls:0.19%
cases:5.75%
controls:0.65%
cases:7.23%
controls:0.96%
59
55
754
8039
45
55
768
8039
14
13
799
8081
—
13
15
799
8054
45
50
738
7701
48
63
616
6521
insulin lispro; parenteral
A10AD04 [21600732]
2.4e+00
2.1e+00
2.4e+00
—
2.1e+00
2.2e+00
2.1e+00
cases:7.13%
controls:0.67%
cases:5.41%
controls:0.68%
cases:1.72%
controls:0.16%
—
—
cases:1.48%
controls:0.19%
cases:5.62%
controls:0.63%
cases:7.08%
controls:0.90%
58
54
755
8040
44
55
769
8039
14
13
799
8081
—
12
15
800
8054
44
49
739
7702
47
59
617
6525
Outpatient Visit
OP [9202]
6.6e-01
9.9e-01
1.2e+00
5.9e+00
1.7e+00
1.7e+00
1.2e+00
cases:77.86%
controls:64.44%
cases:67.65%
controls:43.62%
cases:23.86%
controls:8.88%
cases:60.52%
controls:0.42%
cases:32.76%
controls:8.49%
cases:79.82%
controls:42.32%
cases:88.70%
controls:70.23%
633
5216
180
2878
550
3531
263
4563
194
719
619
7375
492
34
321
8060
266
685
546
7384
625
3280
158
4471
589
4624
75
1960
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 [45552380]
3.2e+00
3.3e+00
—
1.0e+50
—
3.6e+00
2.9e+00
cases:6.15%
controls:0.26%
cases:4.31%
controls:0.17%
—
—
cases:1.48%
controls:0.00%
—
—
cases:5.75%
controls:0.17%
cases:7.38%
controls:0.44%
50
21
763
8073
35
14
778
8080
—
12
0
801
8094
—
45
13
738
7738
49
29
615
6555
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.3e+00
3.4e+00
—
—
—
3.7e+00
3.4e+00
cases:1.72%
controls:0.17%
cases:2.46%
controls:0.09%
—
—
—
—
—
—
cases:2.55%
controls:0.06%
cases:4.07%
controls:0.14%
14
14
799
8080
20
7
793
8087
—
—
—
20
5
763
7746
27
9
637
6575
Other investigative procedure of eye
XCW99 [2001301491]
2.4e+00
3.4e+00
—
1.0e+50
—
4.3e+00
2.5e+00
cases:7.13%
controls:0.67%
cases:6.64%
controls:0.23%
—
—
cases:9.10%
controls:0.00%
—
—
cases:11.49%
controls:0.17%
cases:9.04%
controls:0.77%
58
54
755
8040
54
19
759
8075
—
74
0
739
8094
—
90
13
693
7738
60
51
604
6533
Eye pressure measurement
XCH00 [2001301234]
3.3e+00
3.3e+00
1.0e+50
1.0e+50
—
3.4e+00
2.6e+00
cases:3.69%
controls:0.14%
cases:2.71%
controls:0.10%
cases:0.86%
controls:0.00%
cases:1.60%
controls:0.00%
—
—
cases:3.07%
controls:0.10%
cases:3.77%
controls:0.30%
30
11
783
8083
22
8
791
8086
7
0
806
8094
13
0
800
8094
—
24
8
759
7743
25
20
639
6564
Presence of intraocular lens
Z96.1 [45585885]
1.1e+00
1.9e+00
3.0e+00
1.0e+50
2.3e+00
2.3e+00
2.0e+00
cases:3.69%
controls:1.30%
cases:3.57%
controls:0.56%
cases:1.23%
controls:0.06%
cases:2.58%
controls:0.00%
cases:0.86%
controls:0.09%
cases:4.98%
controls:0.52%
cases:8.28%
controls:1.22%
30
105
783
7989
29
45
784
8049
10
5
803
8089
21
0
792
8094
7
7
805
8062
39
40
744
7711
55
80
609
6504
insulin aspart; parenteral
A10AB05 [21600719]
2.2e+00
2.1e+00
2.3e+00
—
2.1e+00
2.1e+00
1.6e+00
cases:12.42%
controls:1.62%
cases:11.69%
controls:1.63%
cases:3.20%
controls:0.35%
—
—
cases:3.33%
controls:0.43%
cases:12.26%
controls:1.68%
cases:12.35%
controls:2.79%
101
131
712
7963
95
132
718
7962
26
28
787
8066
—
27
35
785
8034
96
130
687
7621
82
184
582
6400
insulin aspart; parenteral
A10AD05 [21600733]
2.2e+00
2.1e+00
2.1e+00
—
2.0e+00
2.1e+00
1.6e+00
cases:12.79%
controls:1.66%
cases:11.93%
controls:1.69%
cases:3.32%
controls:0.41%
—
—
cases:3.45%
controls:0.46%
cases:12.39%
controls:1.74%
cases:12.50%
controls:2.84%
104
134
709
7960
97
137
716
7957
27
33
786
8061
—
28
37
784
8032
97
135
686
7616
83
187
581
6397
dorzolamide
S01EC03 [21603695]
1.4e+00
1.8e+00
2.6e+00
—
2.0e+00
2.2e+00
1.8e+00
cases:2.21%
controls:0.56%
cases:2.21%
controls:0.36%
cases:0.98%
controls:0.07%
—
—
cases:0.74%
controls:0.10%
cases:3.19%
controls:0.36%
cases:3.01%
controls:0.53%
18
45
795
8049
18
29
795
8065
8
6
805
8088
—
6
8
806
8061
25
28
758
7723
20
35
644
6549
insulin (human); parenteral
A10AB01 [21600715]
1.8e+00
2.1e+00
1.8e+00
—
2.1e+00
2.0e+00
1.9e+00
cases:7.75%
controls:1.33%
cases:6.15%
controls:0.78%
cases:1.11%
controls:0.19%
—
—
cases:1.72%
controls:0.21%
cases:5.24%
controls:0.71%
cases:6.48%
controls:1.05%
63
108
750
7986
50
63
763
8031
9
15
804
8079
—
14
17
798
8052
41
55
742
7696
43
69
621
6515
moxonidine; oral
C02AC05 [21600401]
1.7e+00
1.9e+00
2.4e+00
—
2.3e+00
2.0e+00
1.4e+00
cases:3.08%
controls:0.58%
cases:2.83%
controls:0.44%
cases:1.11%
controls:0.10%
—
—
cases:1.60%
controls:0.16%
cases:3.19%
controls:0.45%
cases:3.16%
controls:0.79%
25
47
788
8047
23
36
790
8058
9
8
804
8086
—
13
13
799
8056
25
35
758
7716
21
52
643
6532
insulin (beef); parenteral
A10AD02 [21600730]
2.2e+00
2.0e+00
1.6e+00
—
2.1e+00
1.9e+00
1.7e+00
cases:13.53%
controls:1.75%
cases:12.55%
controls:1.91%
cases:2.46%
controls:0.53%
—
—
cases:3.45%
controls:0.45%
cases:12.26%
controls:1.99%
cases:14.16%
controls:2.87%
110
142
703
7952
102
155
711
7939
20
43
793
8051
—
28
36
784
8033
96
154
687
7597
94
189
570
6395
insulin glargine; parenteral
A10AE04 [21600739]
2.2e+00
2.0e+00
1.6e+00
—
2.1e+00
1.9e+00
1.7e+00
cases:13.53%
controls:1.75%
cases:12.55%
controls:1.91%
cases:2.46%
controls:0.53%
—
—
cases:3.45%
controls:0.45%
cases:12.26%
controls:1.99%
cases:14.16%
controls:2.87%
110
142
703
7952
102
155
711
7939
20
43
793
8051
—
28
36
784
8033
96
154
687
7597
94
189
570
6395
Kidney transplant status
Z94.0 [45566477]
2.5e+00
2.5e+00
—
—
—
2.9e+00
3.5e+00
cases:1.60%
controls:0.14%
cases:1.60%
controls:0.14%
—
—
—
—
—
—
cases:2.30%
controls:0.13%
cases:3.01%
controls:0.09%
13
11
800
8083
13
11
800
8083
—
—
—
18
10
765
7741
20
6
644
6578
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.3e+00
1.7e+00
2.2e+00
—
2.7e+00
1.8e+00
1.6e+00
cases:3.57%
controls:1.01%
cases:3.32%
controls:0.64%
cases:1.11%
controls:0.12%
—
—
cases:1.48%
controls:0.10%
cases:3.83%
controls:0.63%
cases:5.57%
controls:1.17%
29
82
784
8012
27
52
786
8042
9
10
804
8084
—
12
8
800
8061
30
49
753
7702
37
77
627
6507
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
2.2e+00
2.1e+00
2.2e+00
—
1.8e+00
2.3e+00
2.3e+00
cases:4.06%
controls:0.48%
cases:2.83%
controls:0.37%
cases:1.23%
controls:0.14%
—
—
cases:0.62%
controls:0.10%
cases:3.58%
controls:0.37%
cases:7.53%
controls:0.80%
33
39
780
8055
23
30
790
8064
10
11
803
8083
—
5
8
807
8061
28
29
755
7722
50
53
614
6531
Internal Medicine
11 [38004456]
8.2e-01
1.0e+00
1.6e+00
3.5e+00
1.9e+00
1.2e+00
8.6e-01
cases:37.88%
controls:21.13%
cases:20.66%
controls:8.54%
cases:7.87%
controls:1.62%
cases:3.32%
controls:0.10%
cases:8.50%
controls:1.43%
cases:24.14%
controls:8.57%
cases:39.16%
controls:21.39%
308
1710
505
6384
168
691
645
7403
64
131
749
7963
27
8
786
8086
69
115
743
7954
189
664
594
7087
260
1408
404
5176
Chronic kidney disease, unspecified
N18.9 [45553438]
1.1e+00
1.4e+00
2.8e+00
—
2.2e+00
1.7e+00
1.6e+00
cases:1.85%
controls:0.59%
cases:1.48%
controls:0.37%
cases:1.23%
controls:0.07%
—
—
cases:0.99%
controls:0.11%
cases:2.81%
controls:0.50%
cases:4.52%
controls:0.96%
15
48
798
8046
12
30
801
8064
10
6
803
8088
—
8
9
804
8060
22
39
761
7712
30
63
634
6521
Endocrinology
46 [38004485]
1.1e+00
1.9e+00
2.4e+00
—
2.4e+00
1.7e+00
1.4e+00
cases:6.40%
controls:2.17%
cases:6.15%
controls:0.95%
cases:2.21%
controls:0.21%
—
—
cases:2.09%
controls:0.20%
cases:6.00%
controls:1.16%
cases:8.89%
controls:2.38%
52
176
761
7918
50
77
763
8017
18
17
795
8077
—
17
16
795
8053
47
90
736
7661
59
157
605
6427
Essential (primary) hypertension
I10 [45591453]
6.6e-01
8.1e-01
1.6e+00
3.8e+00
1.9e+00
1.1e+00
8.6e-01
cases:26.32%
controls:15.55%
cases:16.48%
controls:8.04%
cases:6.77%
controls:1.47%
cases:5.54%
controls:0.14%
cases:8.13%
controls:1.26%
cases:22.09%
controls:8.57%
cases:37.35%
controls:20.15%
214
1259
599
6835
134
651
679
7443
55
119
758
7975
45
11
768
8083
66
102
746
7967
173
664
610
7087
248
1327
416
5257
darbepoetin alfa; parenteral
B03XA02 [21601134]
2.2e+00
2.6e+00
—
—
—
3.0e+00
2.8e+00
cases:1.23%
controls:0.14%
cases:1.72%
controls:0.14%
—
—
—
—
—
—
cases:2.04%
controls:0.10%
cases:2.71%
controls:0.17%
10
11
803
8083
14
11
799
8083
—
—
—
16
8
767
7743
18
11
646
6573
Photography of fundus of eye
XCK10 [2001301381]
2.0e+00
3.0e+00
—
1.0e+50
—
3.3e+00
2.3e+00
cases:6.15%
controls:0.90%
cases:4.92%
controls:0.26%
—
—
cases:6.15%
controls:0.00%
—
—
cases:8.30%
controls:0.35%
cases:10.24%
controls:1.17%
50
73
763
8021
40
21
773
8073
—
50
0
763
8094
—
65
27
718
7724
68
77
596
6507
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
1.2e+00
1.4e+00
2.2e+00
—
2.6e+00
1.6e+00
1.6e+00
cases:3.20%
controls:0.99%
cases:2.34%
controls:0.58%
cases:0.86%
controls:0.10%
—
—
cases:1.11%
controls:0.09%
cases:2.55%
controls:0.54%
cases:5.57%
controls:1.22%
26
80
787
8014
19
47
794
8047
7
8
806
8086
—
9
7
803
8062
20
42
763
7709
37
80
627
6504
insulin (human); parenteral
A10AD01 [21600729]
1.7e+00
1.9e+00
1.6e+00
—
1.7e+00
1.8e+00
1.7e+00
cases:10.21%
controls:1.94%
cases:8.00%
controls:1.35%
cases:1.35%
controls:0.28%
—
—
cases:2.22%
controls:0.41%
cases:7.28%
controls:1.28%
cases:9.34%
controls:1.82%
83
157
730
7937
65
109
748
7985
11
23
802
8071
—
18
33
794
8036
57
99
726
7652
62
120
602
6464
insulin glulisine; parenteral
A10AB06 [21600720]
2.4e+00
2.5e+00
—
—
—
2.6e+00
2.6e+00
cases:1.11%
controls:0.10%
cases:0.86%
controls:0.07%
—
—
—
—
—
—
cases:0.89%
controls:0.06%
cases:1.36%
controls:0.11%
9
8
804
8086
7
6
806
8088
—
—
—
7
5
776
7746
9
7
655
6577
prazosin; oral
C02CA01 [21600411]
1.9e+00
2.7e+00
—
—
—
2.8e+00
2.6e+00
cases:1.97%
controls:0.30%
cases:2.58%
controls:0.17%
—
—
—
—
—
—
cases:2.81%
controls:0.17%
cases:2.56%
controls:0.20%
16
24
797
8070
21
14
792
8080
—
—
—
22
13
761
7738
17
13
647
6571
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.4e+00
1.5e+00
2.6e+00
—
2.3e+00
1.1e+00
1.2e+00
cases:4.18%
controls:1.11%
cases:2.71%
controls:0.62%
cases:0.98%
controls:0.07%
—
—
cases:0.86%
controls:0.09%
cases:2.04%
controls:0.70%
cases:4.97%
controls:1.53%
34
90
779
8004
22
50
791
8044
8
6
805
8088
—
7
7
805
8062
16
54
767
7697
33
101
631
6483
pH of Venous blood
2746-6 [3012544]
1.3e+00
1.5e+00
2.6e+00
—
2.3e+00
1.0e+00
1.2e+00
cases:4.31%
controls:1.16%
cases:2.83%
controls:0.64%
cases:0.98%
controls:0.07%
—
—
cases:0.86%
controls:0.09%
cases:2.04%
controls:0.74%
cases:4.97%
controls:1.53%
35
94
778
8000
23
52
790
8042
8
6
805
8088
—
7
7
805
8062
16
57
767
7694
33
101
631
6483
Base excess in Venous blood by calculation
1927-3 [3002032]
1.3e+00
1.4e+00
2.6e+00
—
2.3e+00
1.1e+00
1.2e+00
cases:4.18%
controls:1.14%
cases:2.58%
controls:0.63%
cases:0.98%
controls:0.07%
—
—
cases:0.86%
controls:0.09%
cases:2.04%
controls:0.70%
cases:4.97%
controls:1.53%
34
92
779
8002
21
51
792
8043
8
6
805
8088
—
7
7
805
8062
16
54
767
7697
33
101
631
6483
Type 1 diabetes mellitus
E10 [45576436]
2.8e+00
2.5e+00
—
—
—
2.6e+00
2.0e+00
cases:2.95%
controls:0.19%
cases:0.86%
controls:0.07%
—
—
—
—
—
—
cases:1.66%
controls:0.13%
cases:2.56%
controls:0.36%
24
15
789
8079
7
6
806
8088
—
—
—
13
10
770
7741
17
24
647
6560
Outpatient Hospital
22 [8756]
2.9e-01
7.8e-01
1.8e+00
3.2e+00
1.9e+00
1.0e+00
6.9e-01
cases:28.78%
controls:23.28%
cases:13.53%
controls:6.68%
cases:4.55%
controls:0.79%
cases:1.85%
controls:0.07%
cases:4.19%
controls:0.63%
cases:15.58%
controls:6.23%
cases:34.19%
controls:20.64%
234
1884
579
6210
110
541
703
7553
37
64
776
8030
15
6
798
8088
34
51
778
8018
122
483
661
7268
227
1359
437
5225
Type 2 diabetes mellitus, with ophthalmic complications
E11.3 [45591028]
2.5e+00
—
—
1.0e+50
1.0e+50
3.9e+00
3.2e+00
cases:2.21%
controls:0.19%
—
—
—
—
cases:0.98%
controls:0.00%
cases:0.74%
controls:0.00%
cases:3.07%
controls:0.06%
cases:5.12%
controls:0.23%
18
15
795
8079
—
—
8
0
805
8094
6
0
806
8069
24
5
759
7746
34
15
630
6569
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.1e+00
1.2e+00
2.5e+00
—
2.1e+00
1.3e+00
1.3e+00
cases:4.31%
controls:1.51%
cases:3.32%
controls:1.05%
cases:1.85%
controls:0.15%
—
—
cases:1.85%
controls:0.22%
cases:3.83%
controls:1.07%
cases:6.78%
controls:1.99%
35
122
778
7972
27
85
786
8009
15
12
798
8082
—
15
18
797
8051
30
83
753
7668
45
131
619
6453
Office Visit
OMOP4822458 [581477]
6.9e-01
1.4e+00
2.4e+00
1.0e+50
2.5e+00
1.4e+00
1.0e+00
cases:13.04%
controls:6.97%
cases:8.61%
controls:2.31%
cases:2.71%
controls:0.26%
cases:4.06%
controls:0.00%
cases:2.96%
controls:0.25%
cases:8.68%
controls:2.26%
cases:17.02%
controls:7.00%
106
564
707
7530
70
187
743
7907
22
21
791
8073
33
0
780
8094
24
20
788
8049
68
175
715
7576
113
461
551
6123
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
2.0e+00
2.0e+00
—
—
—
2.3e+00
3.0e+00
cases:1.35%
controls:0.19%
cases:1.23%
controls:0.17%
—
—
—
—
—
—
cases:1.40%
controls:0.14%
cases:2.56%
controls:0.14%
11
15
802
8079
10
14
803
8080
—
—
—
11
11
772
7740
17
9
647
6575
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.2e+00
1.4e+00
1.9e+00
—
1.9e+00
1.6e+00
1.2e+00
cases:5.17%
controls:1.54%
cases:3.32%
controls:0.86%
cases:0.86%
controls:0.14%
—
—
cases:1.48%
controls:0.22%
cases:4.21%
controls:0.88%
cases:6.33%
controls:1.94%
42
125
771
7969
27
70
786
8024
7
11
806
8083
—
12
18
800
8051
33
68
750
7683
42
128
622
6456
alfacalcidol; oral, parenteral
A11CC03 [21600818]
2.1e+00
1.9e+00
—
—
—
2.2e+00
2.8e+00
cases:1.97%
controls:0.23%
cases:1.60%
controls:0.23%
—
—
—
—
—
—
cases:2.04%
controls:0.23%
cases:3.46%
controls:0.21%
16
19
797
8075
13
19
800
8075
—
—
—
16
18
767
7733
23
14
641
6570
ciclosporin; oral, parenteral
L04AD01 [21603924]
2.0e+00
1.9e+00
—
—
—
2.5e+00
2.6e+00
cases:1.48%
controls:0.20%
cases:1.11%
controls:0.16%
—
—
—
—
—
—
cases:1.79%
controls:0.15%
cases:2.26%
controls:0.17%
12
16
801
8078
9
13
804
8081
—
—
—
14
12
769
7739
15
11
649
6573
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.2e+00
1.3e+00
1.9e+00
—
1.9e+00
1.5e+00
1.1e+00
cases:5.54%
controls:1.66%
cases:3.20%
controls:0.89%
cases:0.86%
controls:0.12%
—
—
cases:1.48%
controls:0.22%
cases:4.34%
controls:0.99%
cases:6.48%
controls:2.20%
45
134
768
7960
26
72
787
8022
7
10
806
8084
—
12
18
800
8051
34
77
749
7674
43
145
621
6439
calcium carbonate
A02AC01 [21600065]
2.0e+00
2.2e+00
—
—
—
2.5e+00
2.3e+00
cases:1.48%
controls:0.20%
cases:1.60%
controls:0.19%
—
—
—
—
—
—
cases:2.55%
controls:0.22%
cases:3.61%
controls:0.38%
12
16
801
8078
13
15
800
8079
—
—
—
20
17
763
7734
24
25
640
6559
calcium carbonate; oral
A12AA04 [21600863]
2.0e+00
2.2e+00
—
—
—
2.5e+00
2.3e+00
cases:1.48%
controls:0.20%
cases:1.60%
controls:0.19%
—
—
—
—
—
—
cases:2.55%
controls:0.22%
cases:3.61%
controls:0.38%
12
16
801
8078
13
15
800
8079
—
—
—
20
17
763
7734
24
25
640
6559
Atherosclerosis of arteries of extremities
I70.2 [45538421]
1.0e+00
1.4e+00
2.1e+00
1.0e+50
2.1e+00
1.2e+00
1.1e+00
cases:3.44%
controls:1.30%
cases:2.71%
controls:0.68%
cases:0.86%
controls:0.11%
cases:0.62%
controls:0.00%
cases:1.35%
controls:0.16%
cases:2.68%
controls:0.86%
cases:4.82%
controls:1.69%
28
105
785
7989
22
55
791
8039
7
9
806
8085
5
0
808
8094
11
13
801
8056
21
67
762
7684
32
111
632
6473
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.2e+00
1.3e+00
1.9e+00
—
1.9e+00
1.5e+00
1.1e+00
cases:5.90%
controls:1.88%
cases:3.32%
controls:0.96%
cases:0.86%
controls:0.14%
—
—
cases:1.48%
controls:0.22%
cases:4.60%
controls:1.07%
cases:7.08%
controls:2.46%
48
152
765
7942
27
78
786
8016
7
11
806
8083
—
12
18
800
8051
36
83
747
7668
47
162
617
6422
Other healthcare associate professional
Z3229 [2001311561]
1.7e+00
2.2e+00
—
1.0e+50
—
2.8e+00
2.0e+00
cases:2.58%
controls:0.49%
cases:2.09%
controls:0.23%
—
—
cases:1.35%
controls:0.00%
—
—
cases:3.70%
controls:0.23%
cases:5.87%
controls:0.82%
21
40
792
8054
17
19
796
8075
—
11
0
802
8094
—
29
18
754
7733
39
54
625
6530
acetazolamide; oral, parenteral
S01EC01 [21603693]
2.2e+00
2.2e+00
—
—
—
2.5e+00
1.8e+00
cases:1.11%
controls:0.12%
cases:0.74%
controls:0.09%
—
—
—
—
—
—
cases:0.77%
controls:0.06%
cases:1.20%
controls:0.20%
9
10
804
8084
6
7
807
8087
—
—
—
6
5
777
7746
8
13
656
6571
antibiotics in combination with other drugs
S01AA20 [21603571]
6.6e-01
1.3e+00
2.2e+00
—
2.2e+00
1.3e+00
9.6e-01
cases:11.69%
controls:6.38%
cases:6.27%
controls:1.85%
cases:1.97%
controls:0.22%
—
—
cases:0.86%
controls:0.10%
cases:6.64%
controls:1.92%
cases:15.21%
controls:6.46%
95
516
718
7578
51
150
762
7944
16
18
797
8076
—
7
8
805
8061
52
149
731
7602
101
425
563
6159
Parabulbar anesthesia
WX140 [2001310772]
2.5e+00
—
—
—
—
3.2e+00
2.9e+00
cases:1.72%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.79%
controls:0.08%
cases:2.71%
controls:0.15%
14
12
799
8082
—
—
—
—
14
6
769
7745
18
10
646
6574
After-cataract
H26.4 [45600893]
8.8e-01
1.8e+00
2.6e+00
1.0e+50
—
2.2e+00
1.7e+00
cases:1.60%
controls:0.67%
cases:1.11%
controls:0.19%
cases:0.86%
controls:0.06%
cases:0.98%
controls:0.00%
—
—
cases:1.79%
controls:0.19%
cases:3.92%
controls:0.73%
13
54
800
8040
9
15
804
8079
7
5
806
8089
8
0
805
8094
—
14
15
769
7736
26
48
638
6536
Albumin [Mass/volume] in Urine
1754-1 [3012516]
1.2e+00
1.2e+00
2.1e+00
—
1.7e+00
1.1e+00
8.6e-01
cases:14.51%
controls:4.98%
cases:10.58%
controls:3.37%
cases:1.97%
controls:0.23%
—
—
cases:2.09%
controls:0.40%
cases:9.32%
controls:3.17%
cases:15.21%
controls:7.06%
118
403
695
7691
86
273
727
7821
16
19
797
8075
—
17
32
795
8037
73
246
710
7505
101
465
563
6119
Chronic kidney disease
N18 [45582391]
2.2e+00
—
—
—
—
3.2e+00
2.8e+00
cases:1.48%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.06%
cases:1.96%
controls:0.12%
12
13
801
8081
—
—
—
—
12
5
771
7746
13
8
651
6576
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.8e+00
2.4e+00
—
—
—
2.0e+00
2.0e+00
cases:1.60%
controls:0.27%
cases:1.48%
controls:0.14%
—
—
—
—
—
—
cases:1.02%
controls:0.14%
cases:2.41%
controls:0.32%
13
22
800
8072
12
11
801
8083
—
—
—
8
11
775
7740
16
21
648
6563
Gas panel - Venous blood
24339-4 [3000991]
1.4e+00
1.5e+00
—
—
2.4e+00
1.3e+00
1.6e+00
cases:3.57%
controls:0.93%
cases:2.34%
controls:0.54%
—
—
—
—
cases:0.99%
controls:0.09%
cases:2.04%
controls:0.58%
cases:4.97%
controls:1.08%
29
75
784
8019
19
44
794
8050
—
—
8
7
804
8062
16
45
767
7706
33
71
631
6513
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
4.0e+00
—
—
1.0e+50
—
—
4.1e+00
cases:5.66%
controls:0.11%
—
—
—
—
cases:1.23%
controls:0.00%
—
—
—
—
cases:7.68%
controls:0.14%
46
9
767
8085
—
—
10
0
803
8094
—
—
51
9
613
6575
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
1.2e+00
1.2e+00
2.1e+00
—
1.7e+00
1.1e+00
8.5e-01
cases:15.74%
controls:5.40%
cases:11.32%
controls:3.66%
cases:2.09%
controls:0.27%
—
—
cases:2.09%
controls:0.40%
cases:9.71%
controls:3.47%
cases:16.57%
controls:7.85%
128
437
685
7657
92
296
721
7798
17
22
796
8072
—
17
32
795
8037
76
269
707
7482
110
517
554
6067
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
1.1e+00
1.2e+00
2.2e+00
—
1.6e+00
1.1e+00
8.1e-01
cases:14.64%
controls:5.31%
cases:10.70%
controls:3.41%
cases:2.09%
controls:0.23%
—
—
cases:1.97%
controls:0.41%
cases:9.45%
controls:3.32%
cases:15.21%
controls:7.40%
119
430
694
7664
87
276
726
7818
17
19
796
8075
—
16
33
796
8036
74
257
709
7494
101
487
563
6097
prednisolone
S01BA04 [21603621]
1.1e+00
1.4e+00
—
—
2.8e+00
1.8e+00
1.0e+00
cases:3.69%
controls:1.28%
cases:1.85%
controls:0.48%
—
—
—
—
cases:0.99%
controls:0.06%
cases:2.30%
controls:0.39%
cases:4.07%
controls:1.49%
30
104
783
7990
15
39
798
8055
—
—
8
5
804
8064
18
30
765
7721
27
98
637
6486
prednisolone
S03BA02 [21605202]
1.1e+00
1.4e+00
—
—
2.8e+00
1.8e+00
1.0e+00
cases:3.69%
controls:1.28%
cases:1.85%
controls:0.48%
—
—
—
—
cases:0.99%
controls:0.06%
cases:2.30%
controls:0.39%
cases:4.07%
controls:1.49%
30
104
783
7990
15
39
798
8055
—
—
8
5
804
8064
18
30
765
7721
27
98
637
6486
Sicca syndrome [Sjögren]
M35.0 [45562711]
2.0e+00
1.9e+00
—
—
—
2.2e+00
2.0e+00
cases:1.48%
controls:0.21%
cases:1.11%
controls:0.17%
—
—
—
—
—
—
cases:1.28%
controls:0.14%
cases:1.66%
controls:0.23%
12
17
801
8077
9
14
804
8080
—
—
—
10
11
773
7740
11
15
653
6569
timolol, combinations
S01ED51 [21603705]
1.1e+00
1.2e+00
1.8e+00
—
1.2e+00
1.4e+00
1.2e+00
cases:4.06%
controls:1.46%
cases:4.43%
controls:1.37%
cases:2.21%
controls:0.37%
—
—
cases:1.72%
controls:0.53%
cases:5.62%
controls:1.39%
cases:6.33%
controls:1.90%
33
118
780
7976
36
111
777
7983
18
30
795
8064
—
14
43
798
8026
44
108
739
7643
42
125
622
6459
amlodipine; oral
C08CA01 [21601747]
7.6e-01
8.3e-01
1.0e+00
2.0e+00
1.2e+00
1.1e+00
9.1e-01
cases:17.47%
controls:9.02%
cases:15.62%
controls:7.47%
cases:5.78%
controls:2.19%
cases:0.74%
controls:0.10%
cases:6.28%
controls:1.96%
cases:19.54%
controls:7.81%
cases:24.10%
controls:11.28%
142
730
671
7364
127
605
686
7489
47
177
766
7917
6
8
807
8086
51
158
761
7911
153
605
630
7146
160
743
504
5841
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
1.5e+00
2.1e+00
—
—
—
2.4e+00
1.7e+00
cases:1.48%
controls:0.33%
cases:0.98%
controls:0.12%
—
—
—
—
—
—
cases:2.17%
controls:0.21%
cases:2.41%
controls:0.44%
12
27
801
8067
8
10
805
8084
—
—
—
17
16
766
7735
16
29
648
6555
Medical doctor
Z2221 [2001311556]
6.1e-01
9.8e-01
1.8e+00
1.0e+50
1.8e+00
1.4e+00
8.8e-01
cases:6.40%
controls:3.58%
cases:3.81%
controls:1.47%
cases:1.11%
controls:0.19%
cases:2.71%
controls:0.00%
cases:0.99%
controls:0.16%
cases:5.24%
controls:1.33%
cases:7.98%
controls:3.46%
52
290
761
7804
31
119
782
7975
9
15
804
8079
22
0
791
8094
8
13
804
8056
41
103
742
7648
53
228
611
6356
Other disorders of vitreous body
H43.8 [45533329]
1.2e+00
2.0e+00
—
1.0e+50
—
2.5e+00
1.8e+00
cases:1.97%
controls:0.62%
cases:1.48%
controls:0.20%
—
—
cases:0.86%
controls:0.00%
—
—
cases:1.66%
controls:0.14%
cases:3.16%
controls:0.55%
16
50
797
8044
12
16
801
8078
—
7
0
806
8094
—
13
11
770
7740
21
36
643
6548
Extracorporeal dialysis
Z49.1 [45537649]
1.8e+00
2.6e+00
2.5e+00
—
—
—
2.4e+00
cases:0.74%
controls:0.12%
cases:1.11%
controls:0.09%
cases:0.74%
controls:0.06%
—
—
—
—
—
—
cases:1.66%
controls:0.15%
6
10
807
8084
9
7
804
8087
6
5
807
8089
—
—
—
11
10
653
6574
brimonidine
S01GA07 [947915]
1.6e+00
1.6e+00
—
—
—
2.2e+00
1.9e+00
cases:1.60%
controls:0.32%
cases:0.98%
controls:0.20%
—
—
—
—
—
—
cases:2.04%
controls:0.22%
cases:2.26%
controls:0.33%
13
26
800
8068
8
16
805
8078
—
—
—
16
17
767
7734
15
22
649
6562
brimonidine
S01EA05 [21603677]
1.6e+00
1.6e+00
—
—
—
2.2e+00
1.9e+00
cases:1.60%
controls:0.32%
cases:0.98%
controls:0.20%
—
—
—
—
—
—
cases:2.04%
controls:0.22%
cases:2.26%
controls:0.33%
13
26
800
8068
8
16
805
8078
—
—
—
16
17
767
7734
15
22
649
6562
Bilateral
ZXA10 [2001311348]
1.2e+00
2.0e+00
—
1.0e+50
—
2.3e+00
1.7e+00
cases:5.54%
controls:1.73%
cases:2.83%
controls:0.41%
—
—
cases:2.58%
controls:0.00%
—
—
cases:4.47%
controls:0.48%
cases:7.53%
controls:1.44%
45
140
768
7954
23
33
790
8061
—
21
0
792
8094
—
35
37
748
7714
50
95
614
6489
Thorax X-ray examination
GD1AA [2001303617]
7.4e-01
9.2e-01
1.6e+00
1.0e+50
1.9e+00
1.0e+00
9.3e-01
cases:12.67%
controls:6.47%
cases:6.40%
controls:2.64%
cases:2.09%
controls:0.43%
cases:0.86%
controls:0.00%
cases:1.60%
controls:0.24%
cases:6.39%
controls:2.37%
cases:16.87%
controls:7.38%
103
524
710
7570
52
214
761
7880
17
35
796
8059
7
0
806
8094
13
19
799
8050
50
184
733
7567
112
486
552
6098
Right side
ZXA00 [2001311346]
9.1e-01
1.4e+00
—
—
2.3e+00
1.6e+00
8.2e-01
cases:7.50%
controls:3.16%
cases:2.95%
controls:0.75%
—
—
—
—
cases:0.86%
controls:0.09%
cases:3.70%
controls:0.74%
cases:6.78%
controls:3.11%
61
256
752
7838
24
61
789
8033
—
—
7
7
805
8062
29
57
754
7694
45
205
619
6379
azathioprine; oral, parenteral
L04AX01 [21603927]
1.3e+00
1.7e+00
1.6e+00
—
—
1.7e+00
2.1e+00
cases:1.72%
controls:0.46%
cases:1.48%
controls:0.28%
cases:0.62%
controls:0.12%
—
—
—
—
cases:1.53%
controls:0.28%
cases:2.26%
controls:0.27%
14
37
799
8057
12
23
801
8071
5
10
808
8084
—
—
12
22
771
7729
15
18
649
6566
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.1e-01
8.3e-01
1.7e+00
—
1.9e+00
9.5e-01
7.3e-01
cases:6.89%
controls:3.50%
cases:3.44%
controls:1.53%
cases:1.48%
controls:0.28%
—
—
cases:1.11%
controls:0.16%
cases:3.96%
controls:1.57%
cases:7.68%
controls:3.87%
56
283
757
7811
28
124
785
7970
12
23
801
8071
—
9
13
803
8056
31
122
752
7629
51
255
613
6329
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
2.5e+00
2.2e+00
—
—
—
2.2e+00
—
cases:0.86%
controls:0.07%
cases:0.74%
controls:0.09%
—
—
—
—
—
—
cases:0.89%
controls:0.10%
—
—
7
6
806
8088
6
7
807
8087
—
—
—
7
8
776
7743
—
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.6e+00
1.8e+00
—
—
—
1.5e+00
1.9e+00
cases:2.95%
controls:0.62%
cases:2.34%
controls:0.38%
—
—
—
—
—
—
cases:1.66%
controls:0.39%
cases:3.31%
controls:0.53%
24
50
789
8044
19
31
794
8063
—
—
—
13
30
770
7721
22
35
642
6549
Diabetes non-insulin dependent
T90 [2002001131]
8.2e-01
1.0e+00
1.5e+00
—
1.5e+00
1.1e+00
7.4e-01
cases:9.72%
controls:4.53%
cases:8.24%
controls:3.08%
cases:2.21%
controls:0.49%
—
—
cases:2.34%
controls:0.52%
cases:8.68%
controls:3.17%
cases:12.05%
controls:6.15%
79
367
734
7727
67
249
746
7845
18
40
795
8054
—
19
42
793
8027
68
246
715
7505
80
405
584
6179
carvedilol; oral
C07AG02 [21601700]
1.1e+00
1.2e+00
1.8e+00
—
1.3e+00
1.4e+00
1.2e+00
cases:3.08%
controls:1.01%
cases:2.58%
controls:0.83%
cases:1.48%
controls:0.25%
—
—
cases:0.62%
controls:0.17%
cases:2.94%
controls:0.76%
cases:3.31%
controls:1.03%
25
82
788
8012
21
67
792
8027
12
20
801
8074
—
5
14
807
8055
23
59
760
7692
22
68
642
6516
Acute and subacute iridocyclitis
H20.0 [45542994]
1.7e+00
2.6e+00
—
1.0e+50
—
2.4e+00
—
cases:1.72%
controls:0.32%
cases:1.11%
controls:0.09%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.53%
controls:0.14%
—
—
14
26
799
8068
9
7
804
8087
—
5
0
808
8094
—
12
11
771
7740
—
Other chronic renal failure
N18.8 [45534123]
1.4e+00
2.1e+00
—
—
—
2.3e+00
2.2e+00
cases:0.98%
controls:0.23%
cases:1.23%
controls:0.15%
—
—
—
—
—
—
cases:1.15%
controls:0.12%
cases:2.56%
controls:0.30%
8
19
805
8075
10
12
803
8082
—
—
—
9
9
774
7742
17
20
647
6564
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 [2000503133]
3.1e+00
—
—
—
—
3.5e+00
—
cases:1.60%
controls:0.07%
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.06%
—
—
13
6
800
8088
—
—
—
—
16
5
767
7746
—
tacrolimus; oral, parenteral
L04AD02 [21603925]
2.3e+00
2.1e+00
—
—
—
2.2e+00
—
cases:0.86%
controls:0.09%
cases:0.86%
controls:0.11%
—
—
—
—
—
—
cases:1.02%
controls:0.12%
—
—
7
7
806
8087
7
9
806
8085
—
—
—
8
9
775
7742
—
Emergency Room Visit
ER [9203]
4.9e-01
9.6e-01
1.8e+00
—
1.6e+00
7.8e-01
7.6e-01
cases:40.59%
controls:29.50%
cases:23.25%
controls:10.40%
cases:8.00%
controls:1.38%
—
—
cases:6.40%
controls:1.30%
cases:20.95%
controls:10.80%
cases:48.95%
controls:30.94%
330
2388
483
5706
189
842
624
7252
65
112
748
7982
—
52
105
760
7964
164
837
619
6914
325
2037
339
4547
enalapril; oral, parenteral
C09AA02 [21601786]
8.2e-01
8.7e-01
1.1e+00
—
1.5e+00
1.1e+00
1.0e+00
cases:9.59%
controls:4.48%
cases:7.50%
controls:3.30%
cases:3.08%
controls:1.00%
—
—
cases:3.33%
controls:0.74%
cases:9.07%
controls:3.33%
cases:11.30%
controls:4.31%
78
363
735
7731
61
267
752
7827
25
81
788
8013
—
27
60
785
8009
71
258
712
7493
75
284
589
6300
insulin detemir; parenteral
A10AE05 [21600740]
1.9e+00
1.6e+00
1.3e+00
—
9.9e-01
1.5e+00
1.3e+00
cases:6.89%
controls:1.09%
cases:4.31%
controls:0.90%
cases:0.86%
controls:0.25%
—
—
cases:0.86%
controls:0.32%
cases:3.96%
controls:0.94%
cases:5.42%
controls:1.47%
56
88
757
8006
35
73
778
8021
7
20
806
8074
—
7
26
805
8043
31
73
752
7678
36
97
628
6487
Scheduled procedure
ZXD10 [2001311387]
7.2e-01
1.1e+00
1.6e+00
—
2.1e+00
1.6e+00
7.3e-01
cases:10.70%
controls:5.52%
cases:4.43%
controls:1.46%
cases:0.74%
controls:0.15%
—
—
cases:0.99%
controls:0.12%
cases:4.85%
controls:1.03%
cases:8.28%
controls:4.16%
87
447
726
7647
36
118
777
7976
6
12
807
8082
—
8
10
804
8059
38
80
745
7671
55
274
609
6310
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.0e-01
6.2e-01
1.7e+00
—
1.9e+00
8.2e-01
6.5e-01
cases:12.05%
controls:7.65%
cases:7.13%
controls:3.97%
cases:3.32%
controls:0.61%
—
—
cases:3.33%
controls:0.50%
cases:8.68%
controls:4.03%
cases:16.87%
controls:9.61%
98
619
715
7475
58
321
755
7773
27
49
786
8045
—
27
40
785
8029
68
312
715
7439
112
633
552
5951
Physiotherapy
R4110 [2001310233]
6.5e-01
1.0e+00
1.5e+00
—
2.5e+00
1.1e+00
8.5e-01
cases:7.01%
controls:3.78%
cases:3.94%
controls:1.45%
cases:0.86%
controls:0.19%
—
—
cases:0.74%
controls:0.06%
cases:3.96%
controls:1.32%
cases:8.58%
controls:3.84%
57
306
756
7788
32
117
781
7977
7
15
806
8079
—
6
5
806
8064
31
102
752
7649
57
253
607
6331
One hour or less
ZXE00 [2001311394]
5.9e-01
1.3e+00
—
—
2.3e+00
1.3e+00
7.0e-01
cases:8.61%
controls:4.97%
cases:4.55%
controls:1.33%
—
—
—
—
cases:1.23%
controls:0.12%
cases:3.83%
controls:1.10%
cases:7.68%
controls:3.96%
70
402
743
7692
37
108
776
7986
—
—
10
10
802
8059
30
85
753
7666
51
261
613
6323
Social worker
Z2446 [2001311559]
8.6e-01
2.0e+00
—
—
—
2.6e+00
1.5e+00
cases:0.98%
controls:0.42%
cases:1.23%
controls:0.16%
—
—
—
—
—
—
cases:1.15%
controls:0.09%
cases:2.11%
controls:0.47%
8
34
805
8060
10
13
803
8081
—
—
—
9
7
774
7744
14
31
650
6553
Atherosclerotic heart disease
I25.1 [45596196]
6.6e-01
7.3e-01
1.4e+00
—
1.6e+00
1.2e+00
6.2e-01
cases:8.00%
controls:4.30%
cases:4.80%
controls:2.36%
cases:2.09%
controls:0.53%
—
—
cases:2.46%
controls:0.53%
cases:7.15%
controls:2.36%
cases:10.24%
controls:5.80%
65
348
748
7746
39
191
774
7903
17
43
796
8051
—
20
43
792
8026
56
183
727
7568
68
382
596
6202
Oxygen saturation in Venous blood
2711-0 [3024928]
1.9e+00
2.0e+00
—
—
—
1.3e+00
2.2e+00
cases:1.35%
controls:0.20%
cases:0.98%
controls:0.14%
—
—
—
—
—
—
cases:0.64%
controls:0.17%
cases:1.81%
controls:0.21%
11
16
802
8078
8
11
805
8083
—
—
—
5
13
778
7738
12
14
652
6570
levofloxacin
S01AE05 [43534860]
1.2e+00
1.7e+00
—
—
—
2.1e+00
1.1e+00
cases:4.06%
controls:1.31%
cases:2.21%
controls:0.40%
—
—
—
—
—
—
cases:2.94%
controls:0.39%
cases:5.27%
controls:1.79%
33
106
780
7988
18
32
795
8062
—
—
—
23
30
760
7721
35
118
629
6466
ketorolac
S01BC05 [21603643]
1.6e+00
2.5e+00
—
—
—
2.0e+00
1.1e+00
cases:1.85%
controls:0.40%
cases:1.48%
controls:0.12%
—
—
—
—
—
—
cases:0.77%
controls:0.10%
cases:1.66%
controls:0.56%
15
32
798
8062
12
10
801
8084
—
—
—
6
8
777
7743
11
37
653
6547
Vascular Surgery
77 [38004496]
8.4e-01
8.9e-01
1.6e+00
—
1.7e+00
1.5e+00
1.1e+00
cases:4.80%
controls:2.14%
cases:2.58%
controls:1.07%
cases:0.62%
controls:0.12%
—
—
cases:1.11%
controls:0.20%
cases:4.21%
controls:0.98%
cases:7.53%
controls:2.67%
39
173
774
7921
21
87
792
8007
5
10
808
8084
—
9
16
803
8053
33
76
750
7675
50
176
614
6408
nepafenac
S01BC10 [21603648]
1.4e+00
1.7e+00
—
—
—
1.7e+00
1.1e+00
cases:3.32%
controls:0.86%
cases:0.98%
controls:0.17%
—
—
—
—
—
—
cases:1.66%
controls:0.30%
cases:2.41%
controls:0.85%
27
70
786
8024
8
14
805
8080
—
—
—
13
23
770
7728
16
56
648
6528
pH of Serum or Plasma
2753-2 [3018418]
7.0e-01
6.0e-01
1.7e+00
—
1.8e+00
9.9e-01
7.1e-01
cases:8.00%
controls:4.14%
cases:4.06%
controls:2.27%
cases:1.85%
controls:0.33%
—
—
cases:2.09%
controls:0.36%
cases:5.49%
controls:2.12%
cases:10.39%
controls:5.41%
65
335
748
7759
33
184
780
7910
15
27
798
8067
—
17
29
795
8040
43
164
740
7587
69
356
595
6228
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.5e-01
8.8e-01
1.4e+00
—
1.6e+00
8.8e-01
6.6e-01
cases:14.02%
controls:9.40%
cases:8.61%
controls:3.76%
cases:2.58%
controls:0.63%
—
—
cases:2.22%
controls:0.47%
cases:9.20%
controls:4.01%
cases:19.28%
controls:11.01%
114
761
699
7333
70
304
743
7790
21
51
792
8043
—
18
38
794
8031
72
311
711
7440
128
725
536
5859
lercanidipine; oral
C08CA13 [21601759]
8.2e-01
8.4e-01
1.2e+00
—
1.2e+00
1.0e+00
8.4e-01
cases:4.80%
controls:2.16%
cases:4.18%
controls:1.84%
cases:1.85%
controls:0.57%
—
—
cases:2.09%
controls:0.67%
cases:5.75%
controls:2.17%
cases:7.38%
controls:3.33%
39
175
774
7919
34
149
779
7945
15
46
798
8048
—
17
54
795
8015
45
168
738
7583
49
219
615
6365
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
1.5e+00
2.3e+00
—
—
—
—
2.1e+00
cases:1.60%
controls:0.37%
cases:0.86%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.21%
13
30
800
8064
7
7
806
8087
—
—
—
—
11
14
653
6570
furosemide; oral, parenteral
C03CA01 [21601518]
8.2e-01
9.0e-01
9.8e-01
—
1.1e+00
1.1e+00
9.1e-01
cases:13.04%
controls:6.19%
cases:12.92%
controls:5.68%
cases:4.67%
controls:1.80%
—
—
cases:4.80%
controls:1.66%
cases:15.45%
controls:5.61%
cases:19.28%
controls:8.79%
106
501
707
7593
105
460
708
7634
38
146
775
7948
—
39
134
773
7935
121
435
662
7316
128
579
536
6005
Sedation and analgesia
WX002 [2001310758]
1.1e+00
2.0e+00
—
—
—
1.9e+00
9.1e-01
cases:5.41%
controls:1.94%
cases:3.32%
controls:0.47%
—
—
—
—
—
—
cases:2.30%
controls:0.36%
cases:4.22%
controls:1.75%
44
157
769
7937
27
38
786
8056
—
—
—
18
28
765
7723
28
115
636
6469
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
1.3e+00
1.4e+00
—
—
1.1e+00
1.4e+00
1.7e+00
cases:3.81%
controls:1.06%
cases:2.71%
controls:0.68%
—
—
—
—
cases:0.62%
controls:0.21%
cases:2.55%
controls:0.66%
cases:6.78%
controls:1.28%
31
86
782
8008
22
55
791
8039
—
—
5
17
807
8052
20
51
763
7700
45
84
619
6500
Type 1 diabetes mellitus, With unspecified complications
E10.8 [45552384]
3.1e+00
—
—
—
—
—
2.7e+00
cases:1.35%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.09%
11
5
802
8089
—
—
—
—
—
9
6
655
6578
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
7.4e-01
6.5e-01
1.6e+00
—
1.2e+00
7.0e-01
7.3e-01
cases:9.47%
controls:4.76%
cases:4.92%
controls:2.63%
cases:1.85%
controls:0.37%
—
—
cases:1.85%
controls:0.55%
cases:5.49%
controls:2.80%
cases:12.65%
controls:6.52%
77
385
736
7709
40
213
773
7881
15
30
798
8064
—
15
44
797
8025
43
217
740
7534
84
429
580
6155
Rheumatology
66 [38004491]
8.2e-01
7.8e-01
1.1e+00
—
1.7e+00
1.2e+00
1.1e+00
cases:5.17%
controls:2.34%
cases:3.20%
controls:1.49%
cases:0.98%
controls:0.33%
—
—
cases:1.48%
controls:0.27%
cases:4.73%
controls:1.42%
cases:7.38%
controls:2.60%
42
189
771
7905
26
121
787
7973
8
27
805
8067
—
12
22
800
8047
37
110
746
7641
49
171
615
6413
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.1e-01
5.3e-01
1.7e+00
—
1.8e+00
9.0e-01
7.0e-01
cases:10.58%
controls:6.61%
cases:5.90%
controls:3.57%
cases:2.83%
controls:0.53%
—
—
cases:2.96%
controls:0.50%
cases:8.17%
controls:3.48%
cases:15.06%
controls:8.11%
86
535
727
7559
48
289
765
7805
23
43
790
8051
—
24
40
788
8029
64
270
719
7481
100
534
564
6050
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
5.4e-01
1.2e+00
2.0e+00
—
1.8e+00
7.4e-01
6.7e-01
cases:4.67%
controls:2.77%
cases:3.32%
controls:1.04%
cases:0.98%
controls:0.14%
—
—
cases:0.86%
controls:0.15%
cases:2.55%
controls:1.24%
cases:6.78%
controls:3.58%
38
224
775
7870
27
84
786
8010
8
11
805
8083
—
7
12
805
8057
20
96
763
7655
45
236
619
6348
Perimetry
XCK00 [2001301380]
9.8e-01
1.5e+00
—
1.0e+50
1.0e+50
2.6e+00
1.5e+00
cases:1.72%
controls:0.65%
cases:1.35%
controls:0.30%
—
—
cases:1.35%
controls:0.00%
cases:0.74%
controls:0.00%
cases:2.68%
controls:0.21%
cases:2.56%
controls:0.59%
14
53
799
8041
11
24
802
8070
—
11
0
802
8094
6
0
806
8069
21
16
762
7735
17
39
647
6545
Inpatient Hospital
21 [8717]
3.6e-01
7.3e-01
1.6e+00
—
1.4e+00
8.0e-01
6.5e-01
cases:39.48%
controls:31.25%
cases:19.80%
controls:10.66%
cases:7.26%
controls:1.53%
—
—
cases:5.79%
controls:1.47%
cases:20.43%
controls:10.36%
cases:42.62%
controls:28.04%
321
2529
492
5565
161
863
652
7231
59
124
754
7970
—
47
119
765
7950
160
803
623
6948
283
1846
381
4738
Bacteria identified in Isolate by Culture
43409-2 [3042936]
9.3e-01
1.1e+00
2.5e+00
—
—
9.1e-01
9.1e-01
cases:4.06%
controls:1.64%
cases:1.97%
controls:0.67%
cases:0.74%
controls:0.06%
—
—
—
—
cases:1.40%
controls:0.57%
cases:4.22%
controls:1.75%
33
133
780
7961
16
54
797
8040
6
5
807
8089
—
—
11
44
772
7707
28
115
636
6469
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.0e-01
5.1e-01
7.2e-01
2.0e+00
1.1e+00
4.8e-01
3.6e-01
cases:23.74%
controls:18.80%
cases:22.14%
controls:14.59%
cases:6.40%
controls:3.22%
cases:1.72%
controls:0.25%
cases:8.00%
controls:2.85%
cases:21.58%
controls:14.54%
cases:30.27%
controls:23.24%
193
1522
620
6572
180
1181
633
6913
52
261
761
7833
14
20
799
8074
65
230
747
7839
169
1127
614
6624
201
1530
463
5054
nifedipine; oral, parenteral
C08CA05 [21601751]
6.8e-01
1.1e+00
1.7e+00
—
—
1.3e+00
1.3e+00
cases:1.72%
controls:0.88%
cases:1.72%
controls:0.57%
cases:0.98%
controls:0.17%
—
—
—
—
cases:1.66%
controls:0.48%
cases:2.56%
controls:0.73%
14
71
799
8023
14
46
799
8048
8
14
805
8080
—
—
13
37
770
7714
17
48
647
6536
Pharmacy visit
OMOP4822462 [581458]
2.9e-01
7.2e-01
7.3e-01
1.1e+00
8.2e-01
1.1e+00
8.8e-01
cases:92.74%
controls:90.56%
cases:89.42%
controls:80.43%
cases:62.24%
controls:44.38%
cases:7.26%
controls:2.43%
cases:63.67%
controls:43.49%
cases:92.46%
controls:80.52%
cases:96.99%
controls:93.03%
754
7330
59
764
727
6510
86
1584
506
3592
307
4502
59
197
754
7897
517
3509
295
4560
724
6241
59
1510
644
6125
20
459
methylprednisolone; oral, parenteral
H02AB04 [21602732]
9.2e-01
1.4e+00
—
—
—
1.7e+00
1.3e+00
cases:4.67%
controls:1.91%
cases:2.71%
controls:0.67%
—
—
—
—
—
—
cases:3.45%
controls:0.65%
cases:5.12%
controls:1.46%
38
155
775
7939
22
54
791
8040
—
—
—
27
50
756
7701
34
96
630
6488
Type 1 diabetes mellitus, Without complications
E10.9 [45581351]
1.7e+00
1.3e+00
—
—
1.6e+00
1.1e+00
1.2e+00
cases:5.66%
controls:1.04%
cases:2.46%
controls:0.70%
—
—
—
—
cases:0.62%
controls:0.12%
cases:2.17%
controls:0.75%
cases:3.92%
controls:1.20%
46
84
767
8010
20
57
793
8037
—
—
5
10
807
8059
17
58
766
7693
26
79
638
6505
dexamethasone
S01BA01 [21603618]
1.0e+00
1.4e+00
2.0e+00
—
—
6.9e-01
7.7e-01
cases:5.54%
controls:2.05%
cases:2.21%
controls:0.53%
cases:0.74%
controls:0.10%
—
—
—
—
cases:1.53%
controls:0.77%
cases:5.12%
controls:2.43%
45
166
768
7928
18
43
795
8051
6
8
807
8086
—
—
12
60
771
7691
34
160
630
6424
dexamethasone
S03BA01 [21605201]
1.0e+00
1.4e+00
2.0e+00
—
—
6.9e-01
7.7e-01
cases:5.54%
controls:2.05%
cases:2.21%
controls:0.53%
cases:0.74%
controls:0.10%
—
—
—
—
cases:1.53%
controls:0.77%
cases:5.12%
controls:2.43%
45
166
768
7928
18
43
795
8051
6
8
807
8086
—
—
12
60
771
7691
34
160
630
6424
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
1.7e+00
2.1e+00
—
—
—
—
1.4e+00
cases:1.11%
controls:0.20%
cases:0.86%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.11%
controls:0.55%
9
16
804
8078
7
9
806
8085
—
—
—
—
14
36
650
6548
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
2.7e+00
—
—
—
—
—
2.5e+00
cases:1.23%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.09%
10
7
803
8087
—
—
—
—
—
7
6
657
6578
Leukocytes [#/volume] in Urine
30405-5 [3018095]
4.9e-01
7.8e-01
1.3e+00
—
1.3e+00
7.1e-01
5.1e-01
cases:8.49%
controls:5.37%
cases:5.78%
controls:2.74%
cases:1.48%
controls:0.42%
—
—
cases:1.35%
controls:0.36%
cases:5.49%
controls:2.77%
cases:11.60%
controls:7.29%
69
435
744
7659
47
222
766
7872
12
34
801
8060
—
11
29
801
8040
43
215
740
7536
77
480
587
6104
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.1e-01
1.5e+00
2.6e+00
—
—
1.1e+00
8.5e-01
cases:2.09%
controls:1.04%
cases:1.72%
controls:0.37%
cases:0.86%
controls:0.06%
—
—
—
—
cases:1.40%
controls:0.49%
cases:3.01%
controls:1.31%
17
84
796
8010
14
30
799
8064
7
5
806
8089
—
—
11
38
772
7713
20
86
644
6498
Severe anaemia associated with chronic renal failure
138 [2001600134]
2.4e+00
—
—
—
—
1.0e+50
2.6e+00
cases:0.98%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.00%
cases:1.20%
controls:0.09%
8
7
805
8087
—
—
—
—
9
0
774
7751
8
6
656
6578
Case Management Agency
251B00000X [38004193]
1.6e-01
1.9e-01
6.3e-01
3.4e+00
6.5e-01
3.4e-01
1.8e-01
cases:53.51%
controls:49.41%
cases:47.72%
controls:42.91%
cases:28.17%
controls:17.22%
cases:24.23%
controls:1.05%
cases:28.08%
controls:16.97%
cases:53.13%
controls:44.61%
cases:67.92%
controls:63.91%
435
3999
378
4095
388
3473
425
4621
229
1394
584
6700
197
85
616
8009
228
1369
584
6700
416
3458
367
4293
451
4208
213
2376
Pure hypercholesterolaemia
E78.01 [2000501514]
9.3e-01
9.9e-01
1.5e+00
1.0e+50
2.0e+00
1.1e+00
5.1e-01
cases:6.52%
controls:2.68%
cases:3.44%
controls:1.31%
cases:0.86%
controls:0.19%
cases:1.60%
controls:0.00%
cases:1.60%
controls:0.22%
cases:4.85%
controls:1.65%
cases:7.38%
controls:4.56%
53
217
760
7877
28
106
785
7988
7
15
806
8079
13
0
800
8094
13
18
799
8051
38
128
745
7623
49
300
615
6284
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.3e+00
1.8e+00
—
—
—
2.0e+00
1.2e+00
cases:1.60%
controls:0.46%
cases:0.86%
controls:0.15%
—
—
—
—
—
—
cases:1.02%
controls:0.14%
cases:1.51%
controls:0.44%
13
37
800
8057
7
12
806
8082
—
—
—
8
11
775
7740
10
29
654
6555
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.5e+00
2.2e+00
—
—
—
—
1.3e+00
cases:1.23%
controls:0.28%
cases:0.98%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.44%
10
23
803
8071
8
9
805
8085
—
—
—
—
11
29
653
6555
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.3e-01
4.8e-01
7.6e-01
2.4e+00
8.3e-01
5.1e-01
2.9e-01
cases:23.37%
controls:21.08%
cases:19.07%
controls:12.71%
cases:5.66%
controls:2.72%
cases:1.97%
controls:0.19%
cases:5.67%
controls:2.54%
cases:19.41%
controls:12.67%
cases:33.13%
controls:27.07%
190
1706
623
6388
155
1029
658
7065
46
220
767
7874
16
15
797
8079
46
205
766
7864
152
982
631
6769
220
1782
444
4802
diclofenac
S01BC03 [21603641]
8.8e-01
2.8e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:0.74%
controls:0.31%
cases:1.60%
controls:0.10%
—
—
cases:0.62%
controls:0.00%
—
—
cases:0.89%
controls:0.10%
cases:1.20%
controls:0.32%
6
25
807
8069
13
8
800
8086
—
5
0
808
8094
—
7
8
776
7743
8
21
656
6563
Diabetes mellitus screening
171183004 [4064918]
2.8e+00
—
—
—
—
—
2.2e+00
cases:2.34%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:1.81%
controls:0.21%
19
12
794
8082
—
—
—
—
—
12
14
652
6570
Hypertensive renal disease with renal failure
I12.0 [45596187]
—
—
—
—
—
2.5e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.08%
cases:1.20%
controls:0.11%
—
—
—
—
—
7
6
776
7745
8
7
656
6577
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.5e-01
7.3e-01
1.1e+00
—
1.3e+00
7.4e-01
4.8e-01
cases:9.59%
controls:6.31%
cases:6.52%
controls:3.26%
cases:1.85%
controls:0.59%
—
—
cases:2.09%
controls:0.58%
cases:6.51%
controls:3.23%
cases:13.25%
controls:8.66%
78
511
735
7583
53
264
760
7830
15
48
798
8046
—
17
47
795
8022
51
250
732
7501
88
570
576
6014
brinzolamide
S01EC04 [21603696]
1.2e+00
1.1e+00
1.7e+00
—
1.4e+00
1.3e+00
1.3e+00
cases:1.85%
controls:0.58%
cases:1.60%
controls:0.56%
cases:0.74%
controls:0.14%
—
—
cases:0.74%
controls:0.19%
cases:2.04%
controls:0.54%
cases:3.01%
controls:0.88%
15
47
798
8047
13
45
800
8049
6
11
807
8083
—
6
15
806
8054
16
42
767
7709
20
58
644
6526
Chronic hypertension
205 [2001600203]
9.5e-01
1.5e+00
—
—
1.0e+50
2.4e+00
7.0e-01
cases:4.31%
controls:1.70%
cases:2.09%
controls:0.47%
—
—
—
—
cases:0.74%
controls:0.00%
cases:3.19%
controls:0.31%
cases:2.56%
controls:1.29%
35
138
778
7956
17
38
796
8056
—
—
6
0
806
8069
25
24
758
7727
17
85
647
6499
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.7e-01
4.1e-01
7.6e-01
2.2e+00
9.8e-01
4.4e-01
2.8e-01
cases:27.06%
controls:23.88%
cases:25.09%
controls:18.20%
cases:7.75%
controls:3.78%
cases:1.97%
controls:0.22%
cases:8.74%
controls:3.48%
cases:25.54%
controls:18.09%
cases:37.95%
controls:31.67%
220
1933
593
6161
204
1473
609
6621
63
306
750
7788
16
18
797
8076
71
281
741
7788
200
1402
583
6349
252
2085
412
4499
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
1.3e+00
1.9e+00
—
—
—
—
1.5e+00
cases:1.85%
controls:0.52%
cases:0.86%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.11%
controls:0.46%
15
42
798
8052
7
10
806
8084
—
—
—
—
14
30
650
6554
Other senile cataract
H25.8 [45605644]
5.9e-01
1.8e+00
—
1.0e+50
—
1.6e+00
1.5e+00
cases:1.97%
controls:1.10%
cases:1.97%
controls:0.35%
—
—
cases:1.23%
controls:0.00%
—
—
cases:2.04%
controls:0.44%
cases:3.92%
controls:0.94%
16
89
797
8005
16
28
797
8066
—
10
0
803
8094
—
16
34
767
7717
26
62
638
6522
Insulin glargine 300 U / ml
177 [2001600176]
2.5e+00
—
—
—
—
—
2.3e+00
cases:0.86%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.11%
7
6
806
8088
—
—
—
—
—
7
7
657
6577
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
8.9e-01
1.0e+00
1.9e+00
—
1.7e+00
8.6e-01
6.2e-01
cases:5.04%
controls:2.13%
cases:3.20%
controls:1.16%
cases:1.11%
controls:0.16%
—
—
cases:0.62%
controls:0.11%
cases:2.55%
controls:1.10%
cases:5.27%
controls:2.92%
41
172
772
7922
26
94
787
8000
9
13
804
8081
—
5
9
807
8060
20
85
763
7666
35
192
629
6392
brinzolamide, combinations
S01EC54 [45893490]
1.2e+00
1.1e+00
1.5e+00
—
1.3e+00
1.2e+00
1.2e+00
cases:2.09%
controls:0.63%
cases:1.72%
controls:0.58%
cases:0.74%
controls:0.17%
—
—
cases:0.74%
controls:0.20%
cases:2.04%
controls:0.62%
cases:3.31%
controls:1.02%
17
51
796
8043
14
47
799
8047
6
14
807
8080
—
6
16
806
8053
16
48
767
7703
22
67
642
6517
Oxygen saturation in Arterial blood
2708-6 [3016502]
8.6e-01
1.5e+00
2.3e+00
—
—
6.9e-01
7.2e-01
cases:2.71%
controls:1.16%
cases:1.85%
controls:0.41%
cases:0.86%
controls:0.09%
—
—
—
—
cases:1.15%
controls:0.58%
cases:3.01%
controls:1.49%
22
94
791
8000
15
33
798
8061
7
7
806
8087
—
—
9
45
774
7706
20
98
644
6486
Supplier / Service Provider
OMOP5117446 [33004]
-6.2e-01
-6.0e-01
—
—
—
2.4e+00
2.8e+00
cases:15.99%
controls:26.12%
cases:3.94%
controls:6.96%
—
—
—
—
—
—
cases:3.45%
controls:0.31%
cases:12.35%
controls:0.82%
130
2114
683
5980
32
563
781
7531
—
—
—
27
24
756
7727
82
54
582
6530
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
8.2e-01
1.1e+00
2.0e+00
—
1.4e+00
6.3e-01
7.4e-01
cases:3.57%
controls:1.61%
cases:2.09%
controls:0.70%
cases:0.98%
controls:0.14%
—
—
cases:0.62%
controls:0.15%
cases:1.53%
controls:0.83%
cases:4.07%
controls:1.97%
29
130
784
7964
17
57
796
8037
8
11
805
8083
—
5
12
807
8057
12
64
771
7687
27
130
637
6454
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.6e-01
3.9e-01
7.7e-01
2.1e+00
9.6e-01
4.2e-01
2.7e-01
cases:26.81%
controls:23.76%
cases:24.48%
controls:18.01%
cases:7.75%
controls:3.73%
cases:1.72%
controls:0.22%
cases:8.50%
controls:3.42%
cases:25.16%
controls:18.02%
cases:37.65%
controls:31.52%
218
1923
595
6171
199
1458
614
6636
63
302
750
7792
14
18
799
8076
69
276
743
7793
197
1397
586
6354
250
2075
414
4509
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
1.4e+00
2.8e+00
—
—
—
—
1.8e+00
cases:1.23%
controls:0.32%
cases:0.98%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.27%
10
26
803
8068
8
5
805
8089
—
—
—
—
11
18
653
6566
Presence of aortocoronary bypass graft
Z95.1 [45556881]
1.5e+00
1.3e+00
—
—
—
1.6e+00
1.5e+00
cases:2.09%
controls:0.49%
cases:0.62%
controls:0.16%
—
—
—
—
—
—
cases:1.02%
controls:0.21%
cases:2.56%
controls:0.58%
17
40
796
8054
5
13
808
8081
—
—
—
8
16
775
7735
17
38
647
6546
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.3e+00
1.8e+00
—
—
—
—
1.4e+00
cases:1.35%
controls:0.37%
cases:1.11%
controls:0.19%
—
—
—
—
—
—
—
—
cases:2.11%
controls:0.52%
11
30
802
8064
9
15
804
8079
—
—
—
—
14
34
650
6550
Teaching
WZC30 [2001310891]
9.2e-01
1.8e+00
2.0e+00
—
—
1.8e+00
9.0e-02
cases:2.83%
controls:1.15%
cases:2.58%
controls:0.44%
cases:0.62%
controls:0.09%
—
—
—
—
cases:2.81%
controls:0.49%
cases:1.96%
controls:1.79%
23
93
790
8001
21
36
792
8058
5
7
808
8087
—
—
22
38
761
7713
13
118
651
6466
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.4e-01
4.4e-01
7.6e-01
2.0e+00
7.6e-01
4.4e-01
1.7e-01
cases:21.65%
controls:17.82%
cases:19.93%
controls:13.78%
cases:6.89%
controls:3.34%
cases:1.72%
controls:0.23%
cases:6.53%
controls:3.15%
cases:19.67%
controls:13.61%
cases:26.05%
controls:22.87%
176
1442
637
6652
162
1115
651
6979
56
270
757
7824
14
19
799
8075
53
254
759
7815
154
1055
629
6696
173
1506
491
5078
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.1e+00
1.7e+00
—
—
—
—
1.6e+00
cases:1.72%
controls:0.57%
cases:1.48%
controls:0.28%
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.58%
14
46
799
8048
12
23
801
8071
—
—
—
—
19
38
645
6546
Neurology
13 [38004458]
4.6e-01
7.9e-01
8.9e-01
—
1.6e+00
9.3e-01
6.0e-01
cases:14.15%
controls:9.40%
cases:7.87%
controls:3.74%
cases:1.72%
controls:0.72%
—
—
cases:2.83%
controls:0.57%
cases:9.20%
controls:3.86%
cases:16.72%
controls:9.90%
115
761
698
7333
64
303
749
7791
14
58
799
8036
—
23
46
789
8023
72
299
711
7452
111
652
553
5932
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
3.6e-01
7.1e-01
1.0e+00
—
1.3e+00
5.6e-01
3.7e-01
cases:25.09%
controls:18.89%
cases:22.26%
controls:12.38%
cases:4.18%
controls:1.58%
—
—
cases:5.17%
controls:1.41%
cases:19.80%
controls:12.31%
cases:32.98%
controls:25.35%
204
1529
609
6565
181
1002
632
7092
34
128
779
7966
—
42
114
770
7955
155
954
628
6797
219
1669
445
4915
prednisolone
A07EA01 [21600653]
3.4e-01
5.1e-01
1.3e+00
—
1.4e+00
6.2e-01
5.9e-01
cases:12.55%
controls:9.28%
cases:6.89%
controls:4.24%
cases:2.09%
controls:0.61%
—
—
cases:2.96%
controls:0.78%
cases:7.66%
controls:4.26%
cases:18.22%
controls:11.04%
102
751
711
7343
56
343
757
7751
17
49
796
8045
—
24
63
788
8006
60
330
723
7421
121
727
543
5857
fluorometholone
S01BA07 [21603624]
7.2e-01
2.2e+00
—
—
—
2.1e+00
1.2e+00
cases:1.11%
controls:0.54%
cases:1.23%
controls:0.14%
—
—
—
—
—
—
cases:1.15%
controls:0.14%
cases:1.51%
controls:0.46%
9
44
804
8050
10
11
803
8083
—
—
—
9
11
774
7740
10
30
654
6554
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.3e-01
3.7e-01
6.4e-01
2.1e+00
8.8e-01
3.3e-01
2.1e-01
cases:28.29%
controls:25.70%
cases:27.18%
controls:20.57%
cases:8.36%
controls:4.57%
cases:2.34%
controls:0.30%
cases:9.36%
controls:4.10%
cases:26.95%
controls:20.91%
cases:39.16%
controls:34.28%
230
2080
583
6014
221
1665
592
6429
68
370
745
7724
19
24
794
8070
76
331
736
7738
211
1621
572
6130
260
2257
404
4327
prednisolone; oral, parenteral
H02AB06 [21602734]
3.4e-01
5.1e-01
1.3e+00
—
1.3e+00
6.3e-01
5.9e-01
cases:12.55%
controls:9.28%
cases:6.89%
controls:4.24%
cases:2.09%
controls:0.61%
—
—
cases:2.83%
controls:0.78%
cases:7.66%
controls:4.24%
cases:18.22%
controls:10.98%
102
751
711
7343
56
343
757
7751
17
49
796
8045
—
23
63
789
8006
60
329
723
7422
121
723
543
5861
Thyrotropin receptor Ab [Units/volume] in Serum
5385-0 [3017044]
1.8e+00
2.4e+00
—
—
—
—
—
cases:1.48%
controls:0.25%
cases:0.98%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
12
20
801
8074
8
7
805
8087
—
—
—
—
—
Doppler ultrasound examination of heart
FM1DE [2001303299]
8.5e-01
1.5e+00
—
—
—
1.9e+00
7.5e-01
cases:2.46%
controls:1.06%
cases:1.60%
controls:0.37%
—
—
—
—
—
—
cases:1.28%
controls:0.19%
cases:2.26%
controls:1.08%
20
86
793
8008
13
30
800
8064
—
—
—
10
15
773
7736
15
71
649
6513
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.7e-01
3.9e-01
2.6e+00
—
—
6.5e-01
7.9e-01
cases:3.20%
controls:1.51%
cases:1.60%
controls:1.09%
cases:0.98%
controls:0.07%
—
—
—
—
cases:1.92%
controls:1.01%
cases:5.57%
controls:2.60%
26
122
787
7972
13
88
800
8006
8
6
805
8088
—
—
15
78
768
7673
37
171
627
6413
Base excess in Arterial blood by calculation
1925-7 [3003396]
6.8e-01
1.5e+00
2.6e+00
—
—
9.4e-01
6.5e-01
cases:2.58%
controls:1.32%
cases:1.97%
controls:0.46%
cases:0.86%
controls:0.06%
—
—
—
—
cases:1.66%
controls:0.66%
cases:3.16%
controls:1.67%
21
107
792
7987
16
37
797
8057
7
5
806
8089
—
—
13
51
770
7700
21
110
643
6474
FEV1
20150-9 [3024653]
1.0e+00
1.4e+00
-1.0e+50
—
—
1.3e+00
1.7e+00
cases:3.81%
controls:1.40%
cases:1.48%
controls:0.38%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.15%
controls:0.31%
cases:4.22%
controls:0.82%
31
113
782
7981
12
31
801
8063
0
5
813
8089
—
—
9
24
774
7727
28
54
636
6530
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.0e+00
1.4e+00
-1.0e+50
—
—
1.3e+00
1.7e+00
cases:3.81%
controls:1.40%
cases:1.48%
controls:0.38%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.15%
controls:0.31%
cases:4.22%
controls:0.82%
31
113
782
7981
12
31
801
8063
0
5
813
8089
—
—
9
24
774
7727
28
54
636
6530
FEV1/FVC
19926-5 [3011505]
1.0e+00
1.4e+00
-1.0e+50
—
—
1.3e+00
1.7e+00
cases:3.81%
controls:1.40%
cases:1.48%
controls:0.38%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.15%
controls:0.31%
cases:4.22%
controls:0.82%
31
113
782
7981
12
31
801
8063
0
5
813
8089
—
—
9
24
774
7727
28
54
636
6530
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
1.2e+00
1.3e+00
—
—
—
1.4e+00
1.5e+00
cases:3.44%
controls:1.01%
cases:1.85%
controls:0.49%
—
—
—
—
—
—
cases:1.15%
controls:0.28%
cases:4.07%
controls:0.96%
28
82
785
8012
15
40
798
8054
—
—
—
9
22
774
7729
27
63
637
6521
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
9.4e-01
1.1e+00
2.1e+00
—
1.4e+00
7.2e-01
7.6e-01
cases:2.71%
controls:1.07%
cases:2.21%
controls:0.78%
cases:0.86%
controls:0.11%
—
—
cases:0.62%
controls:0.15%
cases:1.92%
controls:0.94%
cases:3.61%
controls:1.73%
22
87
791
8007
18
63
795
8031
7
9
806
8085
—
5
12
807
8057
15
73
768
7678
24
114
640
6470
timolol
S01ED01 [21603699]
9.3e-01
9.3e-01
9.9e-01
—
3.2e-01
1.0e+00
1.2e+00
cases:3.20%
controls:1.28%
cases:2.83%
controls:1.14%
cases:0.86%
controls:0.32%
—
—
cases:0.62%
controls:0.45%
cases:3.07%
controls:1.12%
cases:5.12%
controls:1.67%
26
104
787
7990
23
92
790
8002
7
26
806
8068
—
5
36
807
8033
24
87
759
7664
34
110
630
6474
atorvastatin; oral
C10AA05 [21601860]
5.9e-01
5.9e-01
8.4e-01
—
7.7e-01
7.0e-01
5.6e-01
cases:15.87%
controls:9.46%
cases:14.15%
controls:8.36%
cases:5.41%
controls:2.42%
—
—
cases:4.80%
controls:2.29%
cases:16.60%
controls:8.98%
cases:20.18%
controls:12.67%
129
766
684
7328
115
677
698
7417
44
196
769
7898
—
39
185
773
7884
130
696
653
7055
134
834
530
5750
Standard cardiac ultrasound examination
FM1AE [2001303278]
6.5e-01
8.5e-01
—
—
—
1.6e+00
9.7e-01
cases:4.92%
controls:2.63%
cases:2.46%
controls:1.06%
—
—
—
—
—
—
cases:3.32%
controls:0.72%
cases:6.33%
controls:2.51%
40
213
773
7881
20
86
793
8008
—
—
—
26
56
757
7695
42
165
622
6419
Other seropositive rheumatoid arthritis
M05.8 [45538634]
9.3e-01
8.8e-01
—
—
2.0e+00
9.4e-01
1.1e+00
cases:2.34%
controls:0.94%
cases:1.60%
controls:0.67%
—
—
—
—
cases:0.74%
controls:0.10%
cases:1.79%
controls:0.71%
cases:3.01%
controls:1.05%
19
76
794
8018
13
54
800
8040
—
—
6
8
806
8061
14
55
769
7696
20
69
644
6515
Phakoemulsification with implantation of artificial lens in posterior chamber
CJE20 [2001301342]
6.7e-01
1.3e+00
—
—
—
1.2e+00
8.4e-01
cases:7.38%
controls:3.92%
cases:3.20%
controls:0.90%
—
—
—
—
—
—
cases:4.21%
controls:1.29%
cases:9.34%
controls:4.25%
60
317
753
7777
26
73
787
8021
—
—
—
33
100
750
7651
62
280
602
6304
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.7e-01
8.8e-01
1.3e+00
—
1.3e+00
6.4e-01
6.1e-01
cases:8.12%
controls:4.78%
cases:5.29%
controls:2.27%
cases:1.35%
controls:0.37%
—
—
cases:1.11%
controls:0.31%
cases:4.34%
controls:2.34%
cases:10.69%
controls:6.12%
66
387
747
7707
43
184
770
7910
11
30
802
8064
—
9
25
803
8044
34
181
749
7570
71
403
593
6181
Handing over of treatment supplies
SPAT1262 [2001700363]
1.1e+00
9.2e-01
1.5e+00
—
7.7e-01
9.9e-01
1.0e+00
cases:8.00%
controls:2.94%
cases:4.18%
controls:1.70%
cases:1.11%
controls:0.26%
—
—
cases:0.62%
controls:0.29%
cases:3.96%
controls:1.51%
cases:9.19%
controls:3.49%
65
238
748
7856
34
138
779
7956
9
21
804
8073
—
5
23
807
8046
31
117
752
7634
61
230
603
6354
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.1e+00
1.6e+00
—
—
—
1.1e+00
1.3e+00
cases:1.60%
controls:0.54%
cases:1.35%
controls:0.27%
—
—
—
—
—
—
cases:0.89%
controls:0.30%
cases:2.41%
controls:0.68%
13
44
800
8050
11
22
802
8072
—
—
—
7
23
776
7728
16
45
648
6539
Type 2 diabetes mellitus, with neurological complications
E11.4 [45576442]
1.7e+00
—
—
—
—
2.3e+00
1.5e+00
cases:1.23%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.08%
cases:1.05%
controls:0.24%
10
19
803
8075
—
—
—
—
6
6
777
7745
7
16
657
6568
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.4e+00
1.5e+00
—
—
2.3e+00
1.1e+00
9.9e-01
cases:3.57%
controls:0.89%
cases:2.09%
controls:0.46%
—
—
—
—
cases:0.62%
controls:0.06%
cases:1.53%
controls:0.53%
cases:3.46%
controls:1.32%
29
72
784
8022
17
37
796
8057
—
—
5
5
807
8064
12
41
771
7710
23
87
641
6497
Intravenous
ZX120 [2001311495]
1.2e+00
9.8e-01
—
—
—
1.7e+00
1.0e+00
cases:1.97%
controls:0.61%
cases:0.98%
controls:0.37%
—
—
—
—
—
—
cases:1.40%
controls:0.26%
cases:2.26%
controls:0.82%
16
49
797
8045
8
30
805
8064
—
—
—
11
20
772
7731
15
54
649
6530
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
1.5e+00
8.1e-01
—
—
—
1.3e+00
1.0e+00
cases:1.35%
controls:0.30%
cases:0.86%
controls:0.38%
—
—
—
—
—
—
cases:1.40%
controls:0.37%
cases:2.56%
controls:0.93%
11
24
802
8070
7
31
806
8063
—
—
—
11
29
772
7722
17
61
647
6523
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
6.7e-01
6.0e-01
8.7e-01
—
1.4e+00
6.8e-01
5.0e-01
cases:11.56%
controls:6.25%
cases:6.03%
controls:3.40%
cases:1.23%
controls:0.52%
—
—
cases:1.97%
controls:0.48%
cases:6.90%
controls:3.61%
cases:13.10%
controls:8.35%
94
506
719
7588
49
275
764
7819
10
42
803
8052
—
16
39
796
8030
54
280
729
7471
87
550
577
6034
glucagon; nasal, parenteral
H04AA01 [21602778]
2.2e+00
1.5e+00
—
—
—
2.1e+00
1.7e+00
cases:2.71%
controls:0.31%
cases:0.62%
controls:0.14%
—
—
—
—
—
—
cases:0.64%
controls:0.08%
cases:1.36%
controls:0.26%
22
25
791
8069
5
11
808
8083
—
—
—
5
6
778
7745
9
17
655
6567
bisoprolol; oral
C07AB07 [21601689]
4.7e-01
6.3e-01
7.7e-01
—
5.4e-01
7.5e-01
6.9e-01
cases:21.89%
controls:14.95%
cases:22.26%
controls:13.28%
cases:8.36%
controls:4.05%
—
—
cases:6.65%
controls:3.98%
cases:25.03%
controls:13.62%
cases:30.42%
controls:18.06%
178
1210
635
6884
181
1075
632
7019
68
328
745
7766
—
54
321
758
7748
196
1056
587
6695
202
1189
462
5395
Kuhnt-Junius degeneration
H35.30 [2000502314]
—
—
1.0e+50
1.0e+50
1.0e+50
—
3.8e+00
—
—
—
—
cases:0.86%
controls:0.00%
cases:1.48%
controls:0.00%
cases:1.11%
controls:0.00%
—
—
cases:4.07%
controls:0.09%
—
—
7
0
806
8094
12
0
801
8094
9
0
803
8069
—
27
6
637
6578
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
7.8e-01
1.5e+00
2.3e+00
—
—
9.2e-01
6.2e-01
cases:2.83%
controls:1.32%
cases:2.09%
controls:0.48%
cases:0.86%
controls:0.09%
—
—
—
—
cases:1.53%
controls:0.62%
cases:3.16%
controls:1.73%
23
107
790
7987
17
39
796
8055
7
7
806
8087
—
—
12
48
771
7703
21
114
643
6470
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
7.7e-01
1.5e+00
2.3e+00
—
—
8.9e-01
6.2e-01
cases:2.83%
controls:1.33%
cases:2.09%
controls:0.48%
cases:0.86%
controls:0.09%
—
—
—
—
cases:1.53%
controls:0.63%
cases:3.16%
controls:1.73%
23
108
790
7986
17
39
796
8055
7
7
806
8087
—
—
12
49
771
7702
21
114
643
6470
pH of Arterial blood
2744-1 [3019977]
7.7e-01
1.4e+00
2.3e+00
—
—
9.8e-01
6.4e-01
cases:2.83%
controls:1.33%
cases:1.97%
controls:0.47%
cases:0.86%
controls:0.09%
—
—
—
—
cases:1.66%
controls:0.63%
cases:3.16%
controls:1.69%
23
108
790
7986
16
38
797
8056
7
7
806
8087
—
—
13
49
770
7702
21
111
643
6473
clindamycin; oral, parenteral
J01FF01 [21602985]
6.0e-01
9.9e-01
—
—
—
1.0e+00
1.1e+00
cases:5.17%
controls:2.92%
cases:2.09%
controls:0.79%
—
—
—
—
—
—
cases:2.43%
controls:0.86%
cases:9.04%
controls:3.13%
42
236
771
7858
17
64
796
8030
—
—
—
19
67
764
7684
60
206
604
6378
Other specified counselling
Z71.8 [45581061]
6.7e-01
1.0e+00
1.1e+00
1.0e+50
1.1e+00
1.3e+00
8.0e-01
cases:5.66%
controls:2.98%
cases:4.06%
controls:1.53%
cases:0.74%
controls:0.25%
cases:0.62%
controls:0.00%
cases:1.11%
controls:0.36%
cases:5.11%
controls:1.50%
cases:9.19%
controls:4.33%
46
241
767
7853
33
124
780
7970
6
20
807
8074
5
0
808
8094
9
29
803
8040
40
116
743
7635
61
285
603
6299
tinzaparin; parenteral
B01AB10 [21600981]
7.3e-01
2.1e+00
—
—
—
1.6e+00
8.4e-01
cases:1.35%
controls:0.65%
cases:1.48%
controls:0.19%
—
—
—
—
—
—
cases:1.53%
controls:0.31%
cases:1.96%
controls:0.85%
11
53
802
8041
12
15
801
8079
—
—
—
12
24
771
7727
13
56
651
6528
Vitreous haemorrhage
H43.1 [45543053]
3.7e+00
1.0e+50
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
cases:3.32%
controls:0.09%
cases:3.20%
controls:0.00%
cases:1.11%
controls:0.00%
cases:1.48%
controls:0.00%
cases:1.35%
controls:0.00%
cases:3.32%
controls:0.00%
—
—
27
7
786
8087
26
0
787
8094
9
0
804
8094
12
0
801
8094
11
0
801
8069
26
0
757
7751
—
Physiotherapist
Z3226 [2001311560]
5.7e-01
1.2e+00
—
—
—
1.5e+00
9.7e-01
cases:3.20%
controls:1.84%
cases:1.85%
controls:0.57%
—
—
—
—
—
—
cases:2.68%
controls:0.61%
cases:4.82%
controls:1.88%
26
149
787
7945
15
46
798
8048
—
—
—
21
47
762
7704
32
124
632
6460
Senile nuclear cataract
H25.1 [45581628]
7.7e-01
1.2e+00
1.6e+00
—
1.6e+00
1.0e+00
6.2e-01
cases:6.77%
controls:3.25%
cases:3.44%
controls:1.01%
cases:0.86%
controls:0.17%
—
—
cases:0.74%
controls:0.15%
cases:3.96%
controls:1.46%
cases:7.23%
controls:4.02%
55
263
758
7831
28
82
785
8012
7
14
806
8080
—
6
12
806
8057
31
113
752
7638
48
265
616
6319
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
1.6e+00
2.1e+00
—
—
—
1.6e+00
1.1e+00
cases:1.35%
controls:0.28%
cases:0.98%
controls:0.12%
—
—
—
—
—
—
cases:0.64%
controls:0.13%
cases:1.20%
controls:0.39%
11
23
802
8071
8
10
805
8084
—
—
—
5
10
778
7741
8
26
656
6558
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.0e+00
7.6e-01
—
—
—
1.5e+00
1.1e+00
cases:1.85%
controls:0.67%
cases:0.74%
controls:0.35%
—
—
—
—
—
—
cases:1.40%
controls:0.31%
cases:2.71%
controls:0.93%
15
54
798
8040
6
28
807
8066
—
—
—
11
24
772
7727
18
61
646
6523
empagliflozin; oral
A10BK03 [1123740]
1.2e+00
1.2e+00
6.1e-01
—
1.3e+00
1.2e+00
6.3e-01
cases:2.83%
controls:0.85%
cases:2.71%
controls:0.80%
cases:0.62%
controls:0.33%
—
—
cases:1.23%
controls:0.35%
cases:2.81%
controls:0.89%
cases:2.56%
controls:1.38%
23
69
790
8025
22
65
791
8029
5
27
808
8067
—
10
28
802
8041
22
69
761
7682
17
91
647
6493
Bacteria identified in Blood by Culture
600-7 [3023368]
5.6e-01
8.0e-01
1.6e+00
—
—
4.6e-01
6.8e-01
cases:6.15%
controls:3.62%
cases:3.57%
controls:1.63%
cases:1.11%
controls:0.23%
—
—
—
—
cases:2.55%
controls:1.63%
cases:9.19%
controls:4.89%
50
293
763
7801
29
132
784
7962
9
19
804
8075
—
—
20
126
763
7625
61
322
603
6262
Audiology
64 [38004489]
7.8e-01
9.4e-01
—
—
—
9.0e-01
9.6e-01
cases:4.92%
controls:2.31%
cases:2.34%
controls:0.93%
—
—
—
—
—
—
cases:2.55%
controls:1.06%
cases:7.08%
controls:2.83%
40
187
773
7907
19
75
794
8019
—
—
—
20
82
763
7669
47
186
617
6398
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.9e+00
—
—
—
—
—
1.7e+00
cases:1.23%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.23%
10
15
803
8079
—
—
—
—
—
8
15
656
6569
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
6.6e-01
8.1e-01
1.4e+00
—
1.1e+00
5.1e-01
6.7e-01
cases:7.63%
controls:4.08%
cases:4.18%
controls:1.90%
cases:1.23%
controls:0.30%
—
—
cases:0.74%
controls:0.24%
cases:3.19%
controls:1.94%
cases:9.49%
controls:5.10%
62
330
751
7764
34
154
779
7940
10
24
803
8070
—
6
19
806
8050
25
150
758
7601
63
336
601
6248
felodipine; oral
C08CA02 [21601748]
6.9e-01
7.0e-01
9.2e-01
—
1.1e+00
8.1e-01
9.7e-01
cases:4.06%
controls:2.08%
cases:3.44%
controls:1.74%
cases:0.74%
controls:0.30%
—
—
cases:1.60%
controls:0.55%
cases:3.70%
controls:1.69%
cases:5.72%
controls:2.25%
33
168
780
7926
28
141
785
7953
6
24
807
8070
—
13
44
799
8025
29
131
754
7620
38
148
626
6436
Bacteria [Presence] in Urine
87829-8 [36304419]
6.3e-01
8.0e-01
1.4e+00
—
9.6e-01
5.0e-01
7.3e-01
cases:7.26%
controls:4.02%
cases:4.18%
controls:1.91%
cases:1.23%
controls:0.31%
—
—
cases:0.62%
controls:0.24%
cases:2.94%
controls:1.81%
cases:9.19%
controls:4.66%
59
325
754
7769
34
155
779
7939
10
25
803
8069
—
5
19
807
8050
23
140
760
7611
61
307
603
6277
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
8.5e-01
1.6e+00
—
—
1.8e+00
9.9e-01
1.1e+00
cases:4.18%
controls:1.83%
cases:2.95%
controls:0.62%
—
—
—
—
cases:0.62%
controls:0.10%
cases:1.79%
controls:0.67%
cases:5.27%
controls:1.82%
34
148
779
7946
24
50
789
8044
—
—
5
8
807
8061
14
52
769
7699
35
120
629
6464
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
7.6e-01
1.2e+00
—
—
2.3e+00
1.3e+00
1.1e+00
cases:2.21%
controls:1.05%
cases:1.60%
controls:0.51%
—
—
—
—
cases:0.62%
controls:0.06%
cases:1.66%
controls:0.48%
cases:3.46%
controls:1.17%
18
85
795
8009
13
41
800
8053
—
—
5
5
807
8064
13
37
770
7714
23
77
641
6507
Visual field testing with Octopus automated perimetry
CS444 [2001301477]
1.7e+00
—
—
—
—
—
1.8e+00
cases:1.23%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.23%
10
19
803
8075
—
—
—
—
—
9
15
655
6569
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
8.1e-01
6.4e-01
2.1e+00
—
1.0e+00
1.1e-01
5.6e-01
cases:8.24%
controls:3.83%
cases:2.95%
controls:1.58%
cases:1.35%
controls:0.17%
—
—
cases:0.62%
controls:0.22%
cases:1.53%
controls:1.38%
cases:8.43%
controls:5.01%
67
310
746
7784
24
128
789
7966
11
14
802
8080
—
5
18
807
8051
12
107
771
7644
56
330
608
6254
clopidogrel; oral
B01AC04 [21600989]
7.2e-01
8.7e-01
1.0e+00
—
1.1e+00
1.1e+00
7.2e-01
cases:5.04%
controls:2.52%
cases:3.94%
controls:1.69%
cases:1.35%
controls:0.48%
—
—
cases:1.23%
controls:0.42%
cases:4.73%
controls:1.57%
cases:6.17%
controls:3.11%
41
204
772
7890
32
137
781
7957
11
39
802
8055
—
10
34
802
8035
37
122
746
7629
41
205
623
6379
losartan; oral
C09CA01 [21601824]
5.1e-01
7.1e-01
7.0e-01
—
9.8e-01
7.5e-01
4.9e-01
cases:8.24%
controls:5.13%
cases:8.36%
controls:4.31%
cases:2.46%
controls:1.24%
—
—
cases:3.08%
controls:1.18%
cases:9.71%
controls:4.84%
cases:10.84%
controls:6.93%
67
415
746
7679
68
349
745
7745
20
100
793
7994
—
25
95
787
7974
76
375
707
7376
72
456
592
6128
alfuzosin; oral
G04CA01 [21602668]
7.5e-01
9.5e-01
1.1e+00
—
7.3e-01
9.3e-01
8.0e-01
cases:3.69%
controls:1.78%
cases:2.34%
controls:0.91%
cases:0.86%
controls:0.30%
—
—
cases:0.62%
controls:0.30%
cases:2.43%
controls:0.97%
cases:3.77%
controls:1.73%
30
144
783
7950
19
74
794
8020
7
24
806
8070
—
5
24
807
8045
19
75
764
7676
25
114
639
6470
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
5.6e-02
2.6e-01
6.6e-01
2.0e+00
7.2e-01
2.4e-01
9.6e-02
cases:21.03%
controls:20.13%
cases:18.70%
controls:15.11%
cases:6.15%
controls:3.27%
cases:1.60%
controls:0.22%
cases:6.28%
controls:3.15%
cases:18.52%
controls:15.16%
cases:29.52%
controls:27.55%
171
1629
642
6465
152
1223
661
6871
50
265
763
7829
13
18
800
8076
51
254
761
7815
145
1175
638
6576
196
1814
468
4770
FISTULA - Fistula
FISTULA-1 [2002330212]
—
—
—
—
—
—
3.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.11%
controls:0.08%
—
—
—
—
—
—
14
5
650
6579
Leukocytes [#/volume] in Blood
26464-8 [3010813]
8.4e-02
3.3e-01
5.8e-01
1.8e+00
6.5e-01
2.7e-01
1.6e-01
cases:29.15%
controls:27.45%
cases:28.41%
controls:22.24%
cases:9.10%
controls:5.29%
cases:2.21%
controls:0.38%
cases:9.11%
controls:4.96%
cases:27.59%
controls:22.59%
cases:40.36%
controls:36.59%
237
2222
576
5872
231
1800
582
6294
74
428
739
7666
18
31
795
8063
74
400
738
7669
216
1751
567
6000
268
2409
396
4175
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
8.2e-02
3.3e-01
5.9e-01
1.8e+00
6.4e-01
2.7e-01
1.6e-01
cases:29.15%
controls:27.48%
cases:28.41%
controls:22.26%
cases:9.10%
controls:5.26%
cases:2.21%
controls:0.38%
cases:8.99%
controls:4.93%
cases:27.59%
controls:22.59%
cases:40.36%
controls:36.51%
237
2224
576
5870
231
1802
582
6292
74
426
739
7668
18
31
795
8063
73
398
739
7671
216
1751
567
6000
268
2404
396
4180
MCH [Entitic mass]
28539-5 [3035941]
8.2e-02
3.2e-01
5.9e-01
1.8e+00
6.4e-01
2.6e-01
1.6e-01
cases:29.03%
controls:27.37%
cases:28.29%
controls:22.20%
cases:9.10%
controls:5.24%
cases:2.21%
controls:0.38%
cases:8.99%
controls:4.94%
cases:27.46%
controls:22.55%
cases:40.21%
controls:36.44%
236
2215
577
5879
230
1797
583
6297
74
424
739
7670
18
31
795
8063
73
399
739
7670
215
1748
568
6003
267
2399
397
4185
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
9.1e-01
8.1e-01
1.6e+00
—
1.8e+00
8.1e-01
5.5e-01
cases:5.04%
controls:2.10%
cases:2.95%
controls:1.33%
cases:0.98%
controls:0.20%
—
—
cases:0.74%
controls:0.12%
cases:2.68%
controls:1.21%
cases:5.27%
controls:3.11%
41
170
772
7924
24
108
789
7986
8
16
805
8078
—
6
10
806
8059
21
94
762
7657
35
205
629
6379
Platelets [#/volume] in Blood
26515-7 [3007461]
8.6e-02
3.2e-01
5.9e-01
1.8e+00
6.4e-01
2.6e-01
1.6e-01
cases:29.15%
controls:27.40%
cases:28.29%
controls:22.19%
cases:9.10%
controls:5.26%
cases:2.21%
controls:0.38%
cases:8.99%
controls:4.94%
cases:27.46%
controls:22.55%
cases:40.06%
controls:36.38%
237
2218
576
5876
230
1796
583
6298
74
426
739
7668
18
31
795
8063
73
399
739
7670
215
1748
568
6003
266
2395
398
4189
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
8.4e-02
3.2e-01
5.9e-01
1.8e+00
6.4e-01
2.6e-01
1.7e-01
cases:29.15%
controls:27.44%
cases:28.29%
controls:22.24%
cases:9.10%
controls:5.26%
cases:2.21%
controls:0.38%
cases:8.99%
controls:4.93%
cases:27.46%
controls:22.53%
cases:40.36%
controls:36.45%
237
2221
576
5873
230
1800
583
6294
74
426
739
7668
18
31
795
8063
73
398
739
7671
215
1746
568
6005
268
2400
396
4184
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
8.3e-02
3.2e-01
5.9e-01
1.8e+00
6.4e-01
2.6e-01
1.6e-01
cases:29.15%
controls:27.46%
cases:28.29%
controls:22.24%
cases:9.10%
controls:5.25%
cases:2.21%
controls:0.38%
cases:8.99%
controls:4.96%
cases:27.46%
controls:22.60%
cases:40.36%
controls:36.51%
237
2223
576
5871
230
1800
583
6294
74
425
739
7669
18
31
795
8063
73
400
739
7669
215
1752
568
5999
268
2404
396
4180
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.9e-02
3.2e-01
5.9e-01
1.8e+00
6.4e-01
2.6e-01
1.6e-01
cases:29.03%
controls:27.43%
cases:28.29%
controls:22.25%
cases:9.10%
controls:5.26%
cases:2.21%
controls:0.38%
cases:8.99%
controls:4.94%
cases:27.46%
controls:22.58%
cases:40.36%
controls:36.50%
236
2220
577
5874
230
1801
583
6293
74
426
739
7668
18
31
795
8063
73
399
739
7670
215
1750
568
6001
268
2403
396
4181
Sensorineural hearing loss, bilateral
H90.3 [45576850]
6.1e-01
6.4e-01
1.1e+00
—
2.0e+00
7.9e-01
7.0e-01
cases:5.17%
controls:2.88%
cases:2.34%
controls:1.25%
cases:0.62%
controls:0.20%
—
—
cases:0.74%
controls:0.10%
cases:2.68%
controls:1.24%
cases:6.63%
controls:3.40%
42
233
771
7861
19
101
794
7993
5
16
808
8078
—
6
8
806
8061
21
96
762
7655
44
224
620
6360
Urinary tract ultrasound examination
KH1AE [2001306329]
8.1e-01
—
—
—
—
1.8e+00
1.5e+00
cases:0.86%
controls:0.38%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.14%
cases:2.41%
controls:0.56%
7
31
806
8063
—
—
—
—
7
11
776
7740
16
37
648
6547
Left side
ZXA05 [2001311347]
6.9e-01
1.1e+00
—
—
—
1.5e+00
4.8e-01
cases:5.04%
controls:2.58%
cases:2.21%
controls:0.77%
—
—
—
—
—
—
cases:3.32%
controls:0.76%
cases:4.97%
controls:3.13%
41
209
772
7885
18
62
795
8032
—
—
—
26
59
757
7692
33
206
631
6378
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
9.1e-02
1.6e+00
—
—
—
1.7e+00
7.1e-01
cases:1.23%
controls:1.12%
cases:1.23%
controls:0.25%
—
—
—
—
—
—
cases:1.66%
controls:0.32%
cases:2.26%
controls:1.12%
10
91
803
8003
10
20
803
8074
—
—
—
13
25
770
7726
15
74
649
6510
Plastic And Reconstructive Surgery
24 [38004467]
6.7e-01
1.1e+00
—
—
—
1.5e+00
6.8e-01
cases:3.94%
controls:2.06%
cases:2.34%
controls:0.83%
—
—
—
—
—
—
cases:2.55%
controls:0.55%
cases:4.37%
controls:2.26%
32
167
781
7927
19
67
794
8027
—
—
—
20
43
763
7708
29
149
635
6435
Urgent procedure
ZXD05 [2001311386]
3.1e-01
1.1e+00
2.1e+00
—
—
1.5e+00
6.3e-01
cases:4.67%
controls:3.48%
cases:2.95%
controls:0.99%
cases:0.62%
controls:0.07%
—
—
—
—
cases:3.19%
controls:0.75%
cases:6.33%
controls:3.48%
38
282
775
7812
24
80
789
8014
5
6
808
8088
—
—
25
58
758
7693
42
229
622
6355
Senile incipient cataract
H25.0 [45576699]
1.0e+00
9.2e-01
—
—
—
1.9e+00
1.3e+00
cases:1.23%
controls:0.44%
cases:0.62%
controls:0.25%
—
—
—
—
—
—
cases:1.28%
controls:0.19%
cases:1.96%
controls:0.53%
10
36
803
8058
5
20
808
8074
—
—
—
10
15
773
7736
13
35
651
6549
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
1.4e+00
—
—
—
—
2.0e+00
1.8e+00
cases:1.85%
controls:0.48%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.09%
cases:1.81%
controls:0.29%
15
39
798
8055
—
—
—
—
5
7
778
7744
12
19
652
6565
Ocular fundus photography for diabetic retinopathy screening
CL2S4 [2001301465]
3.1e+00
1.0e+50
—
—
—
—
—
cases:1.97%
controls:0.09%
cases:1.11%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
16
7
797
8087
9
0
804
8094
—
—
—
—
—
Emergency Medicine
93 [38004510]
3.3e-01
7.3e-01
1.6e+00
—
9.1e-01
5.0e-01
3.7e-01
cases:13.65%
controls:10.22%
cases:9.72%
controls:4.95%
cases:3.57%
controls:0.78%
—
—
cases:2.09%
controls:0.86%
cases:9.07%
controls:5.73%
cases:19.28%
controls:14.22%
111
827
702
7267
79
401
734
7693
29
63
784
8031
—
17
69
795
8000
71
444
712
7307
128
936
536
5648
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.6e-01
5.7e-01
1.1e+00
—
9.4e-01
3.4e-01
5.0e-01
cases:14.88%
controls:11.90%
cases:9.59%
controls:5.66%
cases:2.46%
controls:0.82%
—
—
cases:2.09%
controls:0.83%
cases:8.05%
controls:5.88%
cases:21.69%
controls:14.38%
121
963
692
7131
78
458
735
7636
20
66
793
8028
—
17
67
795
8002
63
456
720
7295
144
947
520
5637
Asthma, unspecified
J45.9 [45562456]
4.1e-01
7.2e-01
—
—
1.6e+00
8.9e-01
6.1e-01
cases:4.18%
controls:2.82%
cases:2.83%
controls:1.40%
—
—
—
—
cases:0.99%
controls:0.20%
cases:3.07%
controls:1.28%
cases:6.02%
controls:3.36%
34
228
779
7866
23
113
790
7981
—
—
8
16
804
8053
24
99
759
7652
40
221
624
6363
pH of Specimen
17433-4 [3019225]
4.0e-01
6.4e-01
2.2e+00
—
—
5.9e-01
9.6e-01
cases:2.21%
controls:1.49%
cases:1.35%
controls:0.72%
cases:0.74%
controls:0.09%
—
—
—
—
cases:1.28%
controls:0.71%
cases:3.46%
controls:1.35%
18
121
795
7973
11
58
802
8036
6
7
807
8087
—
—
10
55
773
7696
23
89
641
6495
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
4.5e-01
8.6e-01
2.1e+00
—
—
4.7e-01
1.0e+00
cases:2.09%
controls:1.35%
cases:1.85%
controls:0.79%
cases:0.98%
controls:0.12%
—
—
—
—
cases:1.15%
controls:0.72%
cases:4.37%
controls:1.61%
17
109
796
7985
15
64
798
8030
8
10
805
8084
—
—
9
56
774
7695
29
106
635
6478
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
3.7e-01
7.2e-01
1.3e+00
—
1.8e+00
6.2e-01
3.6e-01
cases:4.18%
controls:2.92%
cases:4.92%
controls:2.46%
cases:0.62%
controls:0.16%
—
—
cases:1.35%
controls:0.24%
cases:4.98%
controls:2.74%
cases:8.73%
controls:6.29%
34
236
779
7858
40
199
773
7895
5
13
808
8081
—
11
19
801
8050
39
212
744
7539
58
414
606
6170
Type 1 diabetes mellitus, With ketoacidosis
E10.1 [45542735]
3.1e+00
—
—
—
—
—
—
cases:1.35%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
11
5
802
8089
—
—
—
—
—
—
pregabalin; oral
N02BF02 [955152]
7.0e-01
8.5e-01
1.1e+00
—
4.8e-01
8.8e-01
5.9e-01
cases:5.54%
controls:2.83%
cases:3.44%
controls:1.49%
cases:1.23%
controls:0.42%
—
—
cases:0.86%
controls:0.53%
cases:3.58%
controls:1.52%
cases:6.93%
controls:3.96%
45
229
768
7865
28
121
785
7973
10
34
803
8060
—
7
43
805
8026
28
118
755
7633
46
261
618
6323
Chronic disorders of vitamin D metabolism
123 [2001600122]
3.0e+00
—
—
—
—
—
—
cases:1.23%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
10
5
803
8089
—
—
—
—
—
—
Arthritis, unspecified
M13.9 [45567463]
1.2e+00
—
-1.0e+50
—
—
1.8e+00
9.2e-01
cases:1.85%
controls:0.58%
—
—
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.02%
controls:0.17%
cases:2.11%
controls:0.85%
15
47
798
8047
—
0
8
813
8086
—
—
8
13
775
7738
14
56
650
6528
Pulmonary Disease
29 [38004472]
5.3e-01
4.2e-01
8.7e-01
—
9.9e-01
7.5e-01
6.9e-01
cases:12.67%
controls:7.85%
cases:6.40%
controls:4.29%
cases:1.72%
controls:0.73%
—
—
cases:1.85%
controls:0.69%
cases:7.79%
controls:3.83%
cases:15.06%
controls:8.17%
103
635
710
7459
52
347
761
7747
14
59
799
8035
—
15
56
797
8013
61
297
722
7454
100
538
564
6046
Headache
R51.80 [2000503603]
4.6e-01
1.4e+00
—
—
—
1.5e+00
5.2e-01
cases:2.09%
controls:1.33%
cases:1.23%
controls:0.30%
—
—
—
—
—
—
cases:1.53%
controls:0.34%
cases:2.71%
controls:1.63%
17
108
796
7986
10
24
803
8070
—
—
—
12
26
771
7725
18
107
646
6477
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.2e-01
4.6e-01
1.1e+00
—
1.1e+00
2.6e-01
3.6e-01
cases:13.90%
controls:11.50%
cases:8.12%
controls:5.28%
cases:2.21%
controls:0.78%
—
—
cases:1.97%
controls:0.68%
cases:6.90%
controls:5.39%
cases:18.98%
controls:14.05%
113
931
700
7163
66
427
747
7667
18
63
795
8031
—
16
55
796
8014
54
418
729
7333
126
925
538
5659
Otolaryngology
4 [38004449]
4.8e-01
4.3e-01
1.3e+00
—
8.3e-01
5.8e-01
5.4e-01
cases:15.13%
controls:9.92%
cases:5.90%
controls:3.90%
cases:1.72%
controls:0.46%
—
—
cases:1.35%
controls:0.59%
cases:6.77%
controls:3.92%
cases:16.42%
controls:10.31%
123
803
690
7291
48
316
765
7778
14
37
799
8057
—
11
48
801
8021
53
304
730
7447
109
679
555
5905
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
6.4e-01
8.7e-01
5.8e-01
—
7.5e-01
8.9e-01
5.0e-01
cases:10.70%
controls:5.92%
cases:6.77%
controls:2.94%
cases:0.62%
controls:0.35%
—
—
cases:0.86%
controls:0.41%
cases:7.02%
controls:3.01%
cases:12.95%
controls:8.26%
87
479
726
7615
55
238
758
7856
5
28
808
8066
—
7
33
805
8036
55
233
728
7518
86
544
578
6040
dexamethasone and antiinfectives
S03CA01 [21605206]
8.2e-01
1.3e+00
—
—
—
6.0e-01
7.4e-01
cases:3.69%
controls:1.66%
cases:1.72%
controls:0.46%
—
—
—
—
—
—
cases:1.15%
controls:0.63%
cases:4.52%
controls:2.20%
30
134
783
7960
14
37
799
8057
—
—
—
9
49
774
7702
30
145
634
6439
Conjunctival surface anesthesia
WX100 [2001310764]
7.6e-01
1.8e+00
—
—
—
1.3e+00
1.1e+00
cases:2.09%
controls:0.99%
cases:1.35%
controls:0.22%
—
—
—
—
—
—
cases:1.28%
controls:0.36%
cases:3.46%
controls:1.22%
17
80
796
8014
11
18
802
8076
—
—
—
10
28
773
7723
23
80
641
6504
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
6.8e-01
1.2e+00
—
—
—
4.9e-01
1.0e+00
cases:4.55%
controls:2.36%
cases:1.97%
controls:0.63%
—
—
—
—
—
—
cases:1.15%
controls:0.71%
cases:6.02%
controls:2.22%
37
191
776
7903
16
51
797
8043
—
—
—
9
55
774
7696
40
146
624
6438
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
1.1e+00
1.7e+00
—
—
—
1.2e+00
1.2e+00
cases:1.48%
controls:0.51%
cases:1.11%
controls:0.21%
—
—
—
—
—
—
cases:0.89%
controls:0.27%
cases:2.26%
controls:0.71%
12
41
801
8053
9
17
804
8077
—
—
—
7
21
776
7730
15
47
649
6537
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
8.8e-01
1.2e+00
—
—
—
1.9e+00
6.8e-01
cases:2.83%
controls:1.20%
cases:0.98%
controls:0.30%
—
—
—
—
—
—
cases:1.15%
controls:0.17%
cases:2.71%
controls:1.40%
23
97
790
7997
8
24
805
8070
—
—
—
9
13
774
7738
18
92
646
6492
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
7.0e-01
7.4e-01
—
—
—
1.4e+00
7.4e-01
cases:4.31%
controls:2.19%
cases:1.60%
controls:0.77%
—
—
—
—
—
—
cases:1.92%
controls:0.50%
cases:4.82%
controls:2.35%
35
177
778
7917
13
62
800
8032
—
—
—
15
39
768
7712
32
155
632
6429
Foot/toe symptom/complaint
L17 [2002000641]
5.6e-01
1.0e-01
2.2e+00
—
—
7.5e-01
6.4e-01
cases:4.92%
controls:2.87%
cases:1.48%
controls:1.33%
cases:0.74%
controls:0.09%
—
—
—
—
cases:2.43%
controls:1.16%
cases:7.83%
controls:4.30%
40
232
773
7862
12
108
801
7986
6
7
807
8087
—
—
19
90
764
7661
52
283
612
6301
More than one and less than three hours
ZXE10 [2001311401]
6.3e-01
6.9e-01
—
—
—
1.3e+00
8.3e-01
cases:8.49%
controls:4.72%
cases:2.46%
controls:1.25%
—
—
—
—
—
—
cases:3.45%
controls:0.94%
cases:8.58%
controls:3.93%
69
382
744
7712
20
101
793
7993
—
—
—
27
73
756
7678
57
259
607
6325
Limited function/disability (L)
L28 [2002000647]
4.8e-01
1.2e+00
1.3e+00
—
1.7e+00
9.6e-01
6.4e-01
cases:2.95%
controls:1.84%
cases:2.71%
controls:0.85%
cases:0.62%
controls:0.16%
—
—
cases:0.86%
controls:0.16%
cases:2.55%
controls:0.99%
cases:5.72%
controls:3.10%
24
149
789
7945
22
69
791
8025
5
13
808
8081
—
7
13
805
8056
20
77
763
7674
38
204
626
6380
CICLOSPORIN - yes
CICLOSPORIN-1 [2002330221]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.08%
—
—
—
—
—
—
8
5
656
6579
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
7.3e-01
1.0e+00
—
—
—
1.6e+00
1.2e+00
cases:1.48%
controls:0.72%
cases:0.62%
controls:0.22%
—
—
—
—
—
—
cases:1.02%
controls:0.21%
cases:2.26%
controls:0.71%
12
58
801
8036
5
18
808
8076
—
—
—
8
16
775
7735
15
47
649
6537
Hemodialysis
TK800 [2001305768]
1.5e+00
—
—
—
1.0e+50
—
2.7e+00
cases:0.74%
controls:0.17%
—
—
—
—
—
—
cases:1.23%
controls:0.00%
—
—
cases:1.81%
controls:0.12%
6
14
807
8080
—
—
—
10
0
802
8069
—
12
8
652
6576
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
6.6e-01
2.7e+00
—
—
—
—
—
cases:0.86%
controls:0.44%
cases:1.11%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
7
36
806
8058
9
6
804
8088
—
—
—
—
—
Non-insulin dependent diabetes diabetic hypoglycaemic coma
E11.00 [2000501437]
1.4e+00
—
—
—
—
—
1.3e+00
cases:1.35%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.44%
11
28
802
8066
—
—
—
—
—
11
29
653
6555
Foot and toes X-ray examination
NH3AA [2001308267]
1.4e+00
—
—
—
—
1.3e+00
1.2e+00
cases:2.09%
controls:0.52%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.18%
cases:2.11%
controls:0.62%
17
42
796
8052
—
—
—
—
5
14
778
7737
14
41
650
6543
Glaucoma suspect
H40.0 [45567051]
2.5e-01
1.1e+00
—
1.0e+50
—
1.5e+00
1.1e+00
cases:0.98%
controls:0.77%
cases:0.86%
controls:0.30%
—
—
cases:0.74%
controls:0.00%
—
—
cases:1.40%
controls:0.31%
cases:2.56%
controls:0.85%
8
62
805
8032
7
24
806
8070
—
6
0
807
8094
—
11
24
772
7727
17
56
647
6528
candesartan; oral
C09CA06 [21601829]
5.1e-01
6.6e-01
5.2e-01
—
2.8e-01
7.5e-01
7.2e-01
cases:7.38%
controls:4.56%
cases:7.38%
controls:3.94%
cases:2.09%
controls:1.25%
—
—
cases:1.60%
controls:1.21%
cases:8.05%
controls:3.97%
cases:10.69%
controls:5.53%
60
369
753
7725
60
319
753
7775
17
101
796
7993
—
13
98
799
7971
63
308
720
7443
71
364
593
6220
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.1e+00
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:3.44%
controls:1.22%
cases:1.23%
controls:0.32%
—
—
—
—
—
—
cases:1.02%
controls:0.30%
cases:3.31%
controls:0.71%
28
99
785
7995
10
26
803
8068
—
—
—
8
23
775
7728
22
47
642
6537
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.1e+00
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:3.44%
controls:1.22%
cases:1.23%
controls:0.32%
—
—
—
—
—
—
cases:1.02%
controls:0.30%
cases:3.31%
controls:0.71%
28
99
785
7995
10
26
803
8068
—
—
—
8
23
775
7728
22
47
642
6537
FEV1 --post bronchodilation
20155-8 [3023550]
1.1e+00
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:3.44%
controls:1.22%
cases:1.23%
controls:0.32%
—
—
—
—
—
—
cases:1.02%
controls:0.30%
cases:3.31%
controls:0.71%
28
99
785
7995
10
26
803
8068
—
—
—
8
23
775
7728
22
47
642
6537
FEV1 percent change
69983-5 [42868472]
1.1e+00
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:3.44%
controls:1.22%
cases:1.23%
controls:0.32%
—
—
—
—
—
—
cases:1.02%
controls:0.30%
cases:3.31%
controls:0.71%
28
99
785
7995
10
26
803
8068
—
—
—
8
23
775
7728
22
47
642
6537
FVC percent change Respiratory system
69982-7 [42868471]
1.1e+00
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:3.44%
controls:1.22%
cases:1.23%
controls:0.32%
—
—
—
—
—
—
cases:1.02%
controls:0.30%
cases:3.31%
controls:0.71%
28
99
785
7995
10
26
803
8068
—
—
—
8
23
775
7728
22
47
642
6537
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
5.3e-01
1.6e+00
2.3e+00
—
—
7.3e-01
1.0e+00
cases:1.35%
controls:0.80%
cases:1.11%
controls:0.23%
cases:0.62%
controls:0.06%
—
—
—
—
cases:0.64%
controls:0.31%
cases:2.26%
controls:0.80%
11
65
802
8029
9
19
804
8075
5
5
808
8089
—
—
5
24
778
7727
15
53
649
6531
Differential panel, method unspecified - Blood
69738-3 [42870588]
5.3e-01
7.4e-01
8.8e-01
—
6.2e-01
6.4e-01
6.9e-01
cases:8.12%
controls:4.94%
cases:5.54%
controls:2.72%
cases:1.60%
controls:0.67%
—
—
cases:0.99%
controls:0.53%
cases:5.11%
controls:2.75%
cases:10.54%
controls:5.59%
66
400
747
7694
45
220
768
7874
13
54
800
8040
—
8
43
804
8026
40
213
743
7538
70
368
594
6216
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
4.9e-01
1.4e+00
—
—
—
8.6e-01
1.2e+00
cases:1.85%
controls:1.14%
cases:1.23%
controls:0.30%
—
—
—
—
—
—
cases:0.64%
controls:0.27%
cases:2.11%
controls:0.67%
15
92
798
8002
10
24
803
8070
—
—
—
5
21
778
7730
14
44
650
6540
Immunoglobulin A (IgA) nephropathy
N08.2*D89.80 [2000503126]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.09%
—
—
—
—
—
—
8
6
656
6578
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.3e+00
7.6e-01
—
—
—
—
1.3e+00
cases:2.21%
controls:0.64%
cases:0.74%
controls:0.35%
—
—
—
—
—
—
—
—
cases:3.46%
controls:0.94%
18
52
795
8042
6
28
807
8066
—
—
—
—
23
62
641
6522
Laboratory Visit
OMOP4822461 [32036]
5.9e-02
2.5e-01
4.2e-01
1.5e+00
6.4e-01
1.8e-01
1.0e-01
cases:31.00%
controls:29.75%
cases:32.23%
controls:27.07%
cases:12.92%
controls:8.90%
cases:2.46%
controls:0.56%
cases:14.78%
controls:8.39%
cases:31.67%
controls:27.89%
cases:42.47%
controls:39.93%
252
2408
561
5686
262
2191
551
5903
105
720
708
7374
20
45
793
8049
120
677
692
7392
248
2162
535
5589
282
2629
382
3955
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.1e-01
5.9e-01
9.3e-01
—
2.0e-01
5.1e-01
5.3e-01
cases:11.07%
controls:6.94%
cases:7.01%
controls:4.00%
cases:2.21%
controls:0.89%
—
—
cases:0.86%
controls:0.71%
cases:6.64%
controls:4.10%
cases:13.70%
controls:8.55%
90
562
723
7532
57
324
756
7770
18
72
795
8022
—
7
57
805
8012
52
318
731
7433
91
563
573
6021
Cardiology
6 [38004451]
5.0e-01
5.7e-01
3.0e-02
—
5.3e-01
8.1e-01
6.7e-01
cases:13.41%
controls:8.60%
cases:7.38%
controls:4.31%
cases:0.74%
controls:0.72%
—
—
cases:1.35%
controls:0.81%
cases:8.68%
controls:4.05%
cases:18.22%
controls:10.19%
109
696
704
7398
60
349
753
7745
6
58
807
8036
—
11
65
801
8004
68
314
715
7437
121
671
543
5913
Dentistry
C5 [903277]
5.5e-01
1.1e+00
—
—
—
1.5e+00
3.5e-01
cases:2.95%
controls:1.72%
cases:1.72%
controls:0.61%
—
—
—
—
—
—
cases:1.92%
controls:0.44%
cases:2.56%
controls:1.82%
24
139
789
7955
14
49
799
8045
—
—
—
15
34
768
7717
17
120
647
6464
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
6.6e-01
2.5e+00
—
—
—
—
—
cases:0.86%
controls:0.44%
cases:1.23%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
7
36
806
8058
10
8
803
8086
—
—
—
—
—
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.4e-01
5.6e-01
9.1e-01
—
4.5e-02
4.6e-01
5.2e-01
cases:11.69%
controls:7.18%
cases:6.89%
controls:4.05%
cases:2.21%
controls:0.90%
—
—
cases:0.74%
controls:0.71%
cases:6.51%
controls:4.21%
cases:13.86%
controls:8.75%
95
581
718
7513
56
328
757
7766
18
73
795
8021
—
6
57
806
8012
51
326
732
7425
92
576
572
6008
Abdominal ultrasound examination
JN3AE [2001305555]
7.1e-01
—
—
—
—
1.4e+00
1.1e+00
cases:1.97%
controls:0.98%
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.34%
cases:3.46%
controls:1.20%
16
79
797
8015
—
—
—
—
11
26
772
7725
23
79
641
6505
chloramphenicol
S03AA08 [21605197]
3.7e-01
5.6e-01
—
—
1.8e+00
7.6e-01
4.5e-01
cases:8.12%
controls:5.77%
cases:3.32%
controls:1.93%
—
—
—
—
cases:0.86%
controls:0.15%
cases:3.58%
controls:1.70%
cases:10.24%
controls:6.76%
66
467
747
7627
27
156
786
7938
—
—
7
12
805
8057
28
132
755
7619
68
445
596
6139
chloramphenicol
S01AA01 [21603554]
3.7e-01
5.6e-01
—
—
1.8e+00
7.6e-01
4.5e-01
cases:8.12%
controls:5.77%
cases:3.32%
controls:1.93%
—
—
—
—
cases:0.86%
controls:0.15%
cases:3.58%
controls:1.70%
cases:10.24%
controls:6.76%
66
467
747
7627
27
156
786
7938
—
—
7
12
805
8057
28
132
755
7619
68
445
596
6139
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
6.9e-01
8.0e-01
—
—
—
1.1e+00
7.4e-01
cases:5.04%
controls:2.61%
cases:2.09%
controls:0.95%
—
—
—
—
—
—
cases:3.07%
controls:1.06%
cases:6.63%
controls:3.28%
41
211
772
7883
17
77
796
8017
—
—
—
24
82
759
7669
44
216
620
6368
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
6.7e-01
6.8e-01
1.7e+00
—
1.5e+00
9.2e-01
9.0e-01
cases:5.66%
controls:2.98%
cases:2.46%
controls:1.26%
cases:0.74%
controls:0.14%
—
—
cases:0.62%
controls:0.14%
cases:3.07%
controls:1.24%
cases:6.93%
controls:2.93%
46
241
767
7853
20
102
793
7992
6
11
807
8083
—
5
11
807
8058
24
96
759
7655
46
193
618
6391
Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.2 [45586127]
2.5e+00
—
—
—
—
—
—
cases:0.74%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
807
8089
—
—
—
—
—
—
Dry eye syndrome
H04.10 [2000502254]
1.1e+00
1.1e+00
—
—
—
1.4e+00
1.4e+00
cases:2.58%
controls:0.86%
cases:1.11%
controls:0.36%
—
—
—
—
—
—
cases:1.15%
controls:0.30%
cases:3.61%
controls:0.94%
21
70
792
8024
9
29
804
8065
—
—
—
9
23
774
7728
24
62
640
6522
metformin; oral
A10BA02 [21600747]
6.2e-01
5.8e-01
5.7e-01
—
3.6e-01
6.3e-01
6.4e-01
cases:15.50%
controls:8.97%
cases:13.78%
controls:8.18%
cases:4.06%
controls:2.35%
—
—
cases:3.33%
controls:2.34%
cases:14.18%
controls:8.08%
cases:17.62%
controls:10.10%
126
726
687
7368
112
662
701
7432
33
190
780
7904
—
27
189
785
7880
111
626
672
7125
117
665
547
5919
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.8e-01
5.3e-01
9.1e-01
—
5.0e-01
4.6e-01
4.5e-01
cases:11.56%
controls:6.83%
cases:8.61%
controls:5.26%
cases:2.95%
controls:1.21%
—
—
cases:1.85%
controls:1.13%
cases:7.66%
controls:4.97%
cases:12.65%
controls:8.48%
94
553
719
7541
70
426
743
7668
24
98
789
7996
—
15
91
797
7978
60
385
723
7366
84
558
580
6026
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
5.7e-01
1.4e+00
2.3e+00
—
—
6.5e-01
1.0e+00
cases:1.35%
controls:0.77%
cases:1.23%
controls:0.30%
cases:0.62%
controls:0.06%
—
—
—
—
cases:0.64%
controls:0.34%
cases:2.26%
controls:0.82%
11
62
802
8032
10
24
803
8070
5
5
808
8089
—
—
5
26
778
7725
15
54
649
6530
Obstetrics / Gynecology
16 [38004461]
-6.3e-03
4.2e-01
1.1e+00
—
1.3e+00
5.2e-01
2.8e-01
cases:10.33%
controls:10.39%
cases:6.03%
controls:4.03%
cases:1.85%
controls:0.61%
—
—
cases:2.09%
controls:0.57%
cases:6.26%
controls:3.83%
cases:12.05%
controls:9.36%
84
841
729
7253
49
326
764
7768
15
49
798
8045
—
17
46
795
8023
49
297
734
7454
80
616
584
5968
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
6.2e-01
9.3e-01
1.2e+00
—
1.3e+00
5.4e-01
8.9e-01
cases:6.40%
controls:3.53%
cases:3.20%
controls:1.28%
cases:0.86%
controls:0.26%
—
—
cases:0.86%
controls:0.25%
cases:2.68%
controls:1.57%
cases:9.64%
controls:4.21%
52
286
761
7808
26
104
787
7990
7
21
806
8073
—
7
20
805
8049
21
122
762
7629
64
277
600
6307
Infectious Disease
44 [38004484]
5.0e-01
1.4e+00
2.0e+00
—
—
9.9e-01
1.1e+00
cases:2.09%
controls:1.27%
cases:1.60%
controls:0.41%
cases:0.62%
controls:0.09%
—
—
—
—
cases:1.40%
controls:0.53%
cases:3.77%
controls:1.34%
17
103
796
7991
13
33
800
8061
5
7
808
8087
—
—
11
41
772
7710
25
88
639
6496
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
4.0e-01
7.8e-01
6.3e-01
—
7.9e-01
8.9e-01
7.7e-01
cases:10.21%
controls:7.05%
cases:5.29%
controls:2.50%
cases:0.74%
controls:0.40%
—
—
cases:1.11%
controls:0.51%
cases:6.13%
controls:2.62%
cases:13.25%
controls:6.61%
83
571
730
7523
43
202
770
7892
6
32
807
8062
—
9
41
803
8028
48
203
735
7548
88
435
576
6149
Thrombin time
3243-3 [3036489]
5.3e-01
2.4e+00
—
—
—
—
6.2e-01
cases:0.86%
controls:0.51%
cases:1.11%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.49%
7
41
806
8053
9
8
804
8086
—
—
—
—
6
32
658
6552
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
7.8e-01
2.4e+00
—
—
—
—
9.1e-01
cases:0.86%
controls:0.40%
cases:1.11%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.30%
7
32
806
8062
9
8
804
8086
—
—
—
—
5
20
659
6564
prednisone
A07EA03 [21600655]
1.0e+00
1.4e+00
—
—
—
8.2e-01
5.7e-01
cases:3.32%
controls:1.20%
cases:1.72%
controls:0.44%
—
—
—
—
—
—
cases:1.28%
controls:0.57%
cases:2.41%
controls:1.38%
27
97
786
7997
14
36
799
8058
—
—
—
10
44
773
7707
16
91
648
6493
prednisone; oral
H02AB07 [21602735]
1.0e+00
1.4e+00
—
—
—
8.2e-01
5.7e-01
cases:3.32%
controls:1.20%
cases:1.72%
controls:0.44%
—
—
—
—
—
—
cases:1.28%
controls:0.57%
cases:2.41%
controls:1.38%
27
97
786
7997
14
36
799
8058
—
—
—
10
44
773
7707
16
91
648
6493
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.2e+00
1.2e+00
—
—
—
—
1.1e+00
cases:2.21%
controls:0.65%
cases:0.74%
controls:0.23%
—
—
—
—
—
—
—
—
cases:2.71%
controls:0.91%
18
53
795
8041
6
19
807
8075
—
—
—
—
18
60
646
6524
Gastroenterology
10 [38004455]
6.3e-01
9.0e-01
1.3e+00
—
1.2e+00
7.4e-01
8.1e-01
cases:7.13%
controls:3.93%
cases:3.44%
controls:1.43%
cases:0.74%
controls:0.20%
—
—
cases:0.62%
controls:0.19%
cases:3.07%
controls:1.48%
cases:8.89%
controls:4.18%
58
318
755
7776
28
116
785
7978
6
16
807
8078
—
5
15
807
8054
24
115
759
7636
59
275
605
6309

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
470
2373
3.21
60.65
7.4
4.0
28.24
7.33
mg/mmol
7.24
355
1540
453
2324
3.05
55.32
6.6
3.4
131.68
42.97
mg/l
5.79
350
1547
465
2452
3.00
53.47
6.6
3.3
6.45
7.76
mmol/l
11.68
412
2094
175
567
3.63
45.35
9.3
3.9
148.00
90.64
ng/l
6.15
164
493
192
680
3.36
43.13
21.2
6.9
13.07
10.36
mmol/l
5.01
183
649
35
22
16.55
41.10
2.5
1.7
—
—
—
0
0
249
1089
2.82
38.14
6.1
2.6
21.49
22.40
%
0.47
238
1017
260
1173
2.76
37.42
6.0
2.5
2.22
2.28
g/l
0.92
245
1088
271
1260
2.70
36.65
6.0
2.6
11.39
12.64
umol/l
2.48
257
1177
196
795
2.91
34.17
9.3
3.5
7.36
7.38
ph
3.69
135
473
226
995
2.74
33.67
20.0
5.7
1.15
1.02
mmol/l
7.41
216
913
194
792
2.88
33.35
9.0
3.5
5.92
5.82
kpa
0.66
187
775
188
762
2.89
32.70
9.3
3.5
1.44
1.97
mmol/l
1.22
166
660
551
3695
2.41
32.04
19.5
7.4
1.21
1.21
mmol/l
0.13
490
3192
598
4278
2.36
28.14
10.4
5.3
7.85
6.68
mmol/l
16.80
576
4073
469
3131
2.12
24.90
4.0
2.4
74.70
77.45
nmol/l
1.49
429
2811
506
3511
2.10
23.81
19.0
16.2
1.28
1.29
inr
0.10
430
2956
153
655
2.63
23.36
15.5
9.5
—
—
—
0
0
40
67
6.22
23.13
1.1
1.2
—
—
—
0
0
352
2189
2.04
21.76
5.5
4.4
—
—
—
0
0
57
139
4.33
21.58
2.0
1.4
—
—
—
0
0
468
3262
1.98
20.49
10.7
5.1
34.88
35.37
g/l
1.00
442
3058
473
3310
1.98
20.46
15.9
6.8
1.21
1.21
mmol/l
0.19
440
3059
42
83
5.27
20.43
2.7
2.7
2.13
0.81
g/24h
2.82
30
48
475
3351
1.95
19.82
8.0
6.3
2.67
2.87
%
1.28
443
3152
480
3414
1.94
19.37
8.1
6.4
24.25
26.92
%
5.84
453
3252
121
504
2.64
19.34
5.1
3.7
7.40
7.42
ph
2.93
108
424
350
2242
1.96
19.30
4.3
3.3
—
—
—
0
0
473
3354
1.93
19.20
8.1
6.4
0.63
0.67
%
0.84
443
3152
148
682
2.42
19.11
5.6
2.8
5.04
4.47
kpa
2.12
143
667
473
3361
1.93
19.00
8.2
6.4
9.11
8.94
%
0.52
441
3164
60
169
3.75
18.66
2.8
2.4
252.75
85.04
ug/min
1.29
43
101
669
5400
2.15
18.10
12.3
8.4
87.68
79.21
u/l
2.57
639
5113
470
3370
1.89
17.97
7.9
6.2
60.64
57.88
%
5.15
445
3216
368
2440
1.90
17.94
6.7
3.4
18.72
88.87
e6/l
1.90
305
1893
50
130
4.03
17.39
2.1
1.4
136.81
173.68
au/ml
1.21
16
33
361
2402
1.88
17.22
7.9
6.1
—
—
—
0
0
303
1906
1.92
17.18
4.5
2.7
376.80
352.39
umol/l
3.05
263
1686
354
2348
1.87
17.00
3.8
3.3
2375.47
1579.31
ng/l
1.62
307
2017
116
503
2.51
16.99
6.3
3.0
120.42
128.74
g/l
3.06
110
493
277
1699
1.94
16.88
5.3
2.7
4.27
5.21
e6/l
1.03
259
1553
348
2300
1.87
16.86
2.7
2.2
307.94
281.57
u/l
0.11
332
2186
497
3674
1.86
16.78
8.0
6.3
1.82
1.86
e9/l
0.14
435
3232
198
1083
2.08
16.66
3.4
2.1
—
—
—
0
0
504
3753
1.85
16.50
8.1
6.5
0.20
0.20
e9/l
0.25
438
3279
211
1188
2.03
16.38
2.7
2.0
29.39
29.52
s
0.10
206
1157
93
371
2.69
16.12
8.1
3.1
24.57
25.37
mmol/l
1.04
88
363
241
1432
1.96
16.00
5.2
4.3
467.42
379.45
ng/l
0.23
205
1165
488
3628
1.82
15.75
8.0
6.2
0.04
0.04
e9/l
0.45
419
3115
49
136
3.76
15.56
1.6
1.2
328.93
268.74
u/ml
0.57
27
77
26
42
6.36
15.54
3.5
1.7
152.69
91.73
ng/l
1.22
26
42
138
672
2.26
15.51
9.3
4.5
7.35
7.35
ph
0.03
102
499
140
686
2.25
15.50
3.5
2.8
69.82
68.94
e9/l
0.10
107
517
210
1202
1.99
15.46
4.9
3.2
2.44
1.92
e6/l
0.44
124
613
586
4627
1.87
15.33
7.1
4.9
8375.67
2133.13
e6/l
0.37
12
77
452
3305
1.79
15.21
2.7
2.2
95.88
95.52
pmol/l
0.05
236
1776
331
2211
1.82
15.08
11.0
4.3
7.39
7.40
ph
0.51
265
1611
484
3617
1.79
15.07
8.0
6.2
0.64
0.60
e9/l
3.18
414
3103
91
372
2.62
15.01
2.1
2.1
1.53
1.52
g/l
0.05
82
336
168
896
2.09
14.98
3.7
2.7
1.80
1.79
%
0.04
152
819
390
2742
1.79
14.91
7.7
4.0
108.09
102.56
e6/l
0.06
312
1983
298
1934
1.84
14.87
3.2
2.2
2.97
2.96
mg/l
0.02
261
1660
441
3219
1.77
14.77
5.7
3.1
157.21
141.60
ug/l
0.50
416
3000
217
1277
1.94
14.65
3.9
3.4
0.82
0.82
mmol/l
0.08
200
1214
315
2093
1.81
14.46
5.8
3.3
0.34
0.43
e6/l
0.33
256
1555
34
76
4.62
14.35
3.5
1.8
11.15
10.36
%
0.52
34
76
46
130
3.68
14.24
10.8
1.4
1.03
0.92
nmol/l
0.31
40
109
87
359
2.59
14.06
4.8
3.9
—
—
—
0
0
131
653
2.19
13.83
2.5
2.4
5.48
7.34
ug/l
1.12
116
575
129
640
2.20
13.78
2.3
3.1
66.33
66.40
g/l
0.04
115
593
344
2385
1.75
13.40
3.4
2.5
—
—
—
0
0
30
64
4.82
13.38
1.7
3.0
1871.33
929.80
mg
1.13
30
64
238
1483
1.84
13.29
5.1
3.0
481.15
538.15
mosm/kgh2o
4.82
217
1299
70
269
2.75
13.01
1.2
1.3
—
—
—
0
0
110
523
2.27
13.00
1.9
2.8
—
—
—
0
0
498
3854
1.71
12.77
6.9
6.7
11.33
11.83
umol/l
0.41
469
3695
213
1300
1.85
12.63
4.7
3.0
1.07
1.00
e6/l
0.08
132
707
96
440
2.33
12.35
14.3
10.9
15.43
15.75
%
0.49
89
427
164
926
1.96
12.30
11.9
8.3
7.40
7.41
ph
1.06
81
537
733
6418
2.08
11.82
12.1
6.4
46.38
39.29
mmol/mol
33.39
685
5998
68
277
2.58
11.27
5.0
4.3
23.87
25.11
mmol/l
2.94
63
259
161
931
1.90
11.17
12.0
8.2
5.05
5.12
kpa
0.33
149
900
161
932
1.90
11.13
12.0
8.2
12.73
11.92
kpa
0.84
150
903
436
3330
1.64
11.12
3.7
2.9
—
—
estimate
—
0
0
67
273
2.58
11.10
2.3
3.9
41.13
42.09
mg/l
0.03
59
231
512
4075
1.65
11.05
9.9
9.7
4.49
4.21
e9/l
1.74
442
3561
147
828
1.94
11.02
12.2
8.5
95.46
95.23
%
0.19
138
807
67
274
2.57
11.02
2.3
3.9
52.24
74.57
mg/l
0.48
59
233
162
944
1.89
10.96
1.5
1.4
698.29
487.22
titre
0.47
35
205
20
19
10.75
10.81
6.9
4.6
—
—
—
0
0
267
1816
1.69
10.61
6.2
4.2
89.94
87.61
%
0.72
260
1785
157
918
1.87
10.48
11.9
8.3
0.45
1.05
mmol/l
1.07
129
752
54
205
2.75
10.29
1.4
1.2
—
—
—
0
0
80
367
2.30
10.25
6.9
4.7
1.36
1.55
%
1.75
72
351
135
758
1.93
10.18
2.8
1.6
—
—
—
0
0
204
1309
1.74
9.94
1.7
1.7
1154.62
1173.46
nmol/l
0.09
153
995
108
568
2.03
9.80
3.0
2.8
11.02
10.64
g/l
0.36
98
521
395
3007
1.59
9.77
5.3
3.5
6.22
6.24
ph
0.13
238
1716
768
6945
2.18
9.77
39.7
20.6
4.04
3.99
mmol/l
6.40
757
6799
32
92
3.58
9.70
1.1
1.1
43.85
80.95
iu/ml
—
6
21
134
764
1.90
9.62
13.6
9.0
114.29
120.68
g/l
2.61
127
752
64
274
2.45
9.57
1.9
2.9
9.98
10.31
g/l
0.23
57
249
767
6943
2.15
9.56
38.8
20.4
139.22
139.64
mmol/l
4.32
757
6809
91
453
2.13
9.55
2.1
1.8
1.11
1.49
g/l
1.14
81
417
29
79
3.77
9.50
1.1
1.2
—
—
—
0
0
753
6777
2.03
9.43
31.7
17.2
26.66
25.61
mg/l
0.40
668
5661
46
168
2.84
9.43
3.0
2.3
120.94
128.26
g/l
1.23
36
130
73
334
2.30
9.41
7.1
4.9
0.82
0.85
%
0.25
65
318
61
259
2.46
9.29
2.2
2.1
21.57
20.72
s
0.50
61
238
374
2836
1.57
9.25
2.4
1.9
1.38
1.33
mmol/l
0.57
324
2397
16
14
11.62
9.09
1.1
1.0
—
—
—
0
0
14
9
15.78
9.05
12.7
13.4
5.06
5.43
mmol/l
—
14
9
340
2534
1.57
9.00
4.8
3.7
—
0.70
—
0
10
151
918
1.79
8.79
2.7
1.6
—
—
—
0
0
58
250
2.42
8.56
2.3
3.8
1.35
2.75
ratio
2.34
35
147
120
685
1.88
8.55
2.1
2.0
387.12
385.25
nmol/l
0.03
110
636
16
16
10.17
8.55
1.0
1.0
—
—
—
0
0
467
3763
1.54
8.55
6.4
4.0
0.03
1.99
estimate
0.49
97
817
123
708
1.86
8.54
3.4
2.3
0.21
0.21
g/l
0.09
116
658
298
2192
1.56
8.17
2.1
1.7
18.90
19.82
nmol/l
0.56
255
1869
466
3775
1.52
8.16
6.6
4.0
0.14
0.40
estimate
0.28
76
767
59
263
2.34
8.09
5.6
3.4
479.31
277.45
mg/l
1.43
36
110
310
2313
1.54
7.91
5.9
2.6
58.42
64.31
u/l
0.75
287
2158
458
3714
1.51
7.86
6.3
3.9
0.00
0.00
estimate
0.50
93
799
110
627
1.87
7.86
4.2
3.3
374.56
231.79
ng/l
1.30
100
585
227
1583
1.59
7.78
1.9
1.7
1.13
1.32
mg/l
0.84
189
1243
222
1556
1.58
7.40
1.4
1.3
2.77
1.25
u/ml
0.88
60
429
318
2425
1.50
7.16
4.2
3.3
43.92
34.39
u/l
0.51
306
2297
200
1379
1.59
7.12
1.8
1.5
2.77
2.52
g/l
0.85
123
846
698
6266
1.66
7.11
6.7
5.1
1.94
1.94
mu/l
0.01
637
5777
14
16
8.88
7.06
1.0
1.0
—
—
—
0
0
25
76
3.36
7.01
1.4
2.7
—
—
—
0
0
167
1110
1.63
6.90
2.9
1.8
—
—
—
0
0
88
489
1.89
6.80
1.6
1.5
—
—
—
0
0
369
2923
1.47
6.76
5.3
4.0
190.47
87.96
ng/l
0.32
301
2120
50
226
2.29
6.67
7.7
6.3
1.56
1.38
mmol/l
0.48
44
200
39
158
2.54
6.60
4.7
2.7
89.78
89.85
%
0.01
39
152
769
7131
1.88
6.47
18.8
12.1
26.77
26.53
u/l
0.12
747
6921
37
148
2.57
6.43
1.6
1.2
—
—
—
0
0
68
354
2.00
6.35
2.1
1.8
2.72
1.42
ug/l
0.60
56
315
596
5224
1.48
6.15
5.0
4.2
14.85
14.88
pmol/l
0.09
543
4795
773
7199
1.88
6.13
40.2
22.3
104.25
80.19
umol/l
11.78
764
7107
149
990
1.61
6.12
1.3
1.2
—
—
—
0
0
277
2109
1.47
6.07
7.8
6.4
—
—
—
0
0
57
286
2.06
5.90
1.9
2.0
8.23
9.20
iu/ml
0.08
18
75
738
6804
1.67
5.79
8.1
5.8
2.37
2.66
mmol/l
15.65
695
6308
108
671
1.70
5.75
4.1
4.4
1.06
0.90
%
0.15
44
215
728
6692
1.64
5.74
7.2
5.1
4.25
4.56
mmol/l
14.24
692
6234
133
877
1.61
5.62
3.7
3.2
4.99
5.61
e9/l
0.36
111
770
102
630
1.70
5.55
4.3
4.5
0.05
0.14
%
1.05
38
175
45
212
2.19
5.48
1.7
1.4
283.33
288.24
ug/g
0.06
33
126
722
6652
1.59
5.31
7.3
5.0
1.37
1.44
mmol/l
4.82
682
6161
382
3141
1.39
5.28
16.9
11.6
0.00
0.00
e9/l
1.09
300
2576
780
7345
1.82
5.09
45.0
25.7
90.93
91.30
fl
1.48
772
7262
780
7346
1.82
5.08
45.2
25.7
248.39
245.81
e9/l
0.51
769
7204
780
7348
1.81
5.04
45.1
25.7
4.38
4.48
e12/l
5.36
769
7186
780
7348
1.81
5.04
45.0
25.6
30.12
30.39
pg
4.37
772
7264
780
7348
1.81
5.04
46.8
26.2
38.94
40.29
%
7.70
772
7260
780
7349
1.81
5.03
45.4
25.9
130.49
135.08
g/l
11.41
772
7267
780
7349
1.81
5.03
45.1
25.8
7.17
6.79
e9/l
3.10
768
7186
39
180
2.22
5.01
2.8
2.9
32.43
33.61
umol/l
0.11
33
160
100
633
1.66
4.96
4.1
4.3
0.94
0.55
%
0.47
42
196
694
6366
1.51
4.91
6.1
4.3
1.37
1.29
mmol/l
2.46
646
5865
105
676
1.63
4.88
4.8
2.4
44.24
35.91
u/l
0.53
83
576
19
62
3.11
4.81
2.3
2.4
—
—
—
0
0
63
353
1.85
4.78
2.6
2.4
—
—
—
0
0
13
25
5.26
4.78
3.6
2.4
0.67
0.59
mmol/l
1.66
13
25
100
643
1.63
4.67
4.5
4.7
0.03
0.16
%
1.15
36
164
87
543
1.67
4.56
1.2
1.2
—
—
—
0
0
22
81
2.76
4.54
1.5
1.6
59.40
63.93
%
0.19
15
57
39
188
2.13
4.53
3.0
2.5
12.81
12.15
mg/l
0.18
33
172
249
1946
1.40
4.50
1.4
1.4
—
—
—
0
0
124
851
1.54
4.39
3.3
2.7
7.25
8.89
umol/l
0.60
108
758
331
2722
1.36
4.33
2.4
2.2
—
—
—
0
0
14
34
4.17
4.22
2.6
3.8
534.79
1067.29
u/ml
0.77
14
34
37
180
2.10
4.21
1.5
1.7
—
—
—
0
0
17
57
3.02
4.14
2.9
2.7
9.28
8.38
mmol/l
0.46
17
57
27
116
2.37
4.12
1.9
1.8
0.60
0.82
g/l
0.50
19
93
127
892
1.50
4.04
2.0
1.4
—
—
—
0
0
62
371
1.72
3.82
3.3
3.5
4.26
4.47
pmol/l
0.65
52
331
117
818
1.50
3.80
1.4
1.4
—
—
—
0
0
54
311
1.79
3.79
2.6
2.1
—
—
—
0
0
34
168
2.07
3.74
5.0
3.8
—
—
—
0
0
254
2044
1.35
3.72
6.1
3.5
0.57
0.06
estimate
0.71
72
631
59
353
1.72
3.65
2.8
2.2
0.00
2.39
estimate
0.50
13
105
85
559
1.58
3.65
4.9
2.8
5.97
6.09
ph
0.51
68
379
79
514
1.59
3.55
17.0
10.4
1.17
1.30
%
1.01
79
509
33
165
2.04
3.54
2.0
1.8
6.30
5.04
iu/l
0.15
15
57
26
120
2.20
3.41
1.2
1.5
30.73
30.43
g/l
0.04
21
107
70
447
1.62
3.40
2.6
2.6
54.98
22.71
au/ml
—
5
38
97
669
1.51
3.37
2.9
2.1
0.00
0.02
estimate
0.50
21
137
78
514
1.57
3.33
17.2
10.6
93.86
93.89
%
0.01
78
509
61
380
1.65
3.27
1.2
1.2
—
—
—
0
0
89
607
1.52
3.26
1.6
1.4
—
—
—
0
0
300
2515
1.30
3.21
5.0
3.4
2.35
2.35
mmol/l
0.09
277
2270
8
15
5.37
3.19
6.8
8.3
5.71
5.35
kpa
—
8
15
31
158
2.00
3.18
10.1
6.9
12.96
11.29
mmol/l
1.41
23
147
31
158
2.00
3.18
10.1
6.9
104.04
105.33
mmol/l
0.48
23
147
516
4641
1.29
3.16
4.7
3.3
61.00
50.28
u/l
1.64
476
4378
333
2839
1.29
3.11
6.5
3.9
0.01
0.04
estimate
0.78
78
667
35
192
1.86
2.92
1.6
1.2
1.26
2.62
u/ml
—
5
23
11
32
3.47
2.90
1.5
1.5
40.09
55.69
ug/l
0.90
11
32
7
13
5.42
2.87
1.4
1.3
—
—
—
0
0
8
18
4.48
2.80
1.0
1.4
29.88
26.78
s
—
8
18
35
195
1.83
2.80
5.7
4.6
—
—
—
0
0
15
59
2.57
2.80
1.1
1.1
—
—
—
0
0
18
79
2.31
2.69
1.6
1.2
—
—
nmol/l
—
0
0
20
92
2.20
2.69
1.2
1.3
2.13
6.85
u/ml
1.19
15
41
193
1561
1.31
2.64
1.8
1.7
446.14
25364420.08
pmol/l
1.24
164
1305
732
6966
1.38
2.62
27.5
15.4
—
—
—
0
0
14
55
2.57
2.62
2.0
1.2
110.71
101.87
pmol/l
0.23
14
55
46
287
1.64
2.51
1.4
1.2
1.38
1.48
u/ml
—
6
21
18
82
2.22
2.49
2.1
2.2
—
—
—
0
0
72
500
1.48
2.47
10.9
6.6
23.40
24.45
mmol/l
1.64
64
482
112
844
1.38
2.46
3.0
2.5
228.18
131.59
ug/g
1.10
93
684
14
57
2.48
2.46
2.7
2.8
14.44
16.28
%
1.25
14
57
21
103
2.07
2.43
1.2
1.3
1557.36
1637.32
e6/l
0.05
11
69
5
8
6.28
2.37
1.2
1.4
—
—
—
0
0
81
582
1.43
2.34
8.2
4.1
1.23
1.23
mmol/l
0.02
73
508
70
489
1.47
2.34
2.7
1.7
—
—
—
0
0
693
6568
1.31
2.34
6.7
5.2
6.89
5.97
mmol/l
18.01
626
6023
15
65
2.33
2.32
1.5
1.2
0.36
0.41
g/l
—
9
47
15
65
2.33
2.32
1.5
1.2
6.35
6.50
g/l
—
9
48
15
65
2.33
2.32
1.5
1.2
2.54
2.87
g/l
—
9
48
6
13
4.64
2.27
1.5
1.2
91.00
67.38
nmol/24h
—
6
13
15
66
2.30
2.25
1.5
1.2
—
—
—
0
0
20
100
2.02
2.22
1.1
1.1
5.34
5.78
u/ml
0.03
12
54
20
100
2.02
2.22
1.0
1.1
1.60
0.90
u/ml
—
9
41
16
73
2.21
2.22
4.9
2.4
—
—
—
0
0
21
107
1.99
2.22
2.9
2.5
104.71
105.27
mmol/l
0.20
21
107
21
107
1.99
2.22
2.9
2.5
4.10
4.08
mmol/l
0.06
21
107
6
14
4.31
2.15
1.2
1.6
—
—
—
0
0
10
36
2.80
2.14
1.9
3.7
78.10
169.47
nmol/l
—
10
36
18
88
2.07
2.12
1.3
1.3
59016.00
36102.53
e6/l
—
6
49
29
475
0.60
2.03
1.3
1.8
3.01
3.47
mmol/l
1.07
18
349
8
26
3.10
2.01
1.1
1.1
—
—
—
0
0
24
134
1.81
1.97
1.4
1.3
—
—
—
0
0
11
45
2.46
1.93
1.7
1.8
41.90
37.18
%
0.50
11
45
16
78
2.07
1.92
1.3
1.2
—
—
—
0
0
33
204
1.64
1.92
1.4
1.6
15129.92
13923.53
e6/l
0.08
25
146
19
99
1.94
1.91
2.1
1.6
—
—
—
0
0
20
107
1.89
1.87
3.0
2.5
1.18
1.19
mmol/l
0.61
20
107
8
28
2.87
1.86
1.3
1.1
—
—
—
0
0
8
28
2.87
1.86
1.3
1.1
—
—
—
0
0
8
28
2.87
1.86
9.8
3.3
—
—
—
0
0
17
86
2.00
1.86
1.2
1.3
—
—
—
0
0
19
101
1.90
1.82
1.5
1.5
—
—
—
0
0
19
101
1.90
1.82
1.5
1.5
—
—
—
0
0
19
101
1.90
1.82
1.5
1.5
—
—
—
0
0
19
101
1.90
1.82
1.5
1.5
—
—
—
0
0
12
53
2.28
1.81
1.2
1.1
—
—
—
0
0
8
29
2.77
1.79
9.8
3.2
—
—
—
0
0
8
30
2.68
1.72
1.0
1.1
139.62
184.19
mmol/24h
—
8
30
14
68
2.08
1.71
2.1
1.3
21.87
30.09
ng/l
0.66
14
68
17
89
1.93
1.71
1.2
1.6
—
—
—
0
0
13
62
2.11
1.66
1.4
1.2
—
—
—
0
0
34
221
1.56
1.64
1.3
1.1
—
—
—
0
0
243
2127
1.20
1.60
6.3
3.9
0.00
0.01
estimate
1.15
80
739
8
32
2.51
1.60
1.3
1.9
38.65
40.05
g/l
—
8
32
10
44
2.29
1.56
1.0
1.1
295.10
225.13
mg/l
—
10
39
6
21
2.87
1.50
1.2
1.6
—
—
—
0
0
5
16
3.14
1.44
1.8
1.9
—
—
—
0
0
19
110
1.74
1.44
1.2
1.1
—
—
—
0
0
6
22
2.74
1.43
3.3
2.8
3.17
6.50
ug/l
—
6
22
10
46
2.19
1.40
1.1
1.1
54.85
39.38
mg/l
—
10
38
9
41
2.21
1.37
1.3
2.0
—
—
—
0
0
63
480
1.34
1.36
7.8
4.7
—
—
—
0
0
29
191
1.54
1.36
1.6
1.3
7.72
8.75
u/l
0.18
23
151
59
449
1.34
1.30
1.4
1.3
312.63
219.80
u/ml
0.24
54
415
298
2697
1.16
1.29
4.7
5.6
7.67
2.39
ug/l
0.71
269
2420
193
1687
1.19
1.28
7.0
4.1
1.02
1.02
kg/l
0.50
159
1119
18
108
1.68
1.23
1.1
1.1
—
—
—
0
0
5
19
2.64
1.21
2.0
1.4
33.40
32.95
%
—
5
19
182
1593
1.18
1.19
5.4
4.8
—
—
—
0
0
8
38
2.12
1.18
1.1
1.1
1837.00
1551.61
miu/ml
—
8
38
138
1182
1.20
1.15
1.3
1.3
10.54
12.87
u/ml
0.18
45
452
5
20
2.51
1.15
1.4
1.7
—
—
—
0
0
7
30
2.34
1.12
1.7
1.4
—
1.50
—
0
6
11
58
1.91
1.12
1.6
1.4
41.60
32.05
%
—
5
38
19
119
1.61
1.12
1.0
1.2
0.33
1.99
u/ml
—
10
63
236
2609
0.87
1.08
4.3
3.2
—
—
—
0
0
16
99
1.63
1.00
1.0
1.1
0.19
1.82
u/ml
—
8
48
15
93
1.62
0.94
1.3
1.4
—
—
—
0
0
145
1272
1.17
0.94
1.4
1.3
24.98
34.43
iu/ml
1.01
46
386
11
63
1.76
0.90
1.5
1.2
—
—
—
0
0
6
29
2.08
0.89
2.2
3.7
25.17
30.50
umol/l
—
6
21
12
71
1.70
0.89
1.3
1.2
—
—
—
0
0
10
56
1.80
0.88
1.5
1.5
88.10
79.70
umol/l
—
10
56
8
45
1.79
0.84
1.3
1.5
125.53
161.40
pmol/l
—
8
45
11
178
0.61
0.83
1.1
1.2
—
—
—
0
0
8
47
1.71
0.81
1.4
1.7
—
—
—
0
0
46
572
0.79
0.79
6.4
3.7
—
—
—
0
0
92
792
1.18
0.77
3.2
4.4
108.26
20.18
ug/l
0.40
73
671
164
1477
1.14
0.76
3.5
3.0
2.47
2.45
mmol/l
1.14
143
1324
14
91
1.55
0.75
1.1
1.1
1.36
1.78
u/ml
—
6
42
30
228
1.33
0.73
1.1
1.1
—
—
—
0
0
14
92
1.53
0.72
1.4
1.3
—
—
—
0
0
13
84
1.56
0.72
1.0
1.1
1.22
3.68
u/ml
—
5
34
26
194
1.35
0.72
5.8
3.3
7.71
1.94
index
0.42
14
106
39
309
1.27
0.72
1.3
1.2
—
—
—
0
0
40
319
1.27
0.70
2.5
2.9
—
—
—
0
0
16
226
0.70
0.67
1.5
1.5
—
—
—
0
0
10
62
1.62
0.65
1.6
1.3
—
—
—
0
0
7
44
1.60
0.65
8.0
3.4
0.29
0.93
index
—
7
44
29
226
1.29
0.62
1.9
1.6
9.43
10.32
u/ml
—
6
51
8
51
1.57
0.60
1.3
1.1
—
—
—
0
0
52
438
1.20
0.58
1.3
1.2
244.05
131.05
u/ml
0.57
14
170
21
159
1.33
0.55
1.8
2.0
1902.30
2857.60
u/l
—
7
57
17
228
0.74
0.55
1.5
1.5
—
—
—
0
0
17
227
0.74
0.54
1.5
1.5
—
—
—
0
0
17
226
0.75
0.52
1.5
1.5
—
—
—
0
0
10
66
1.52
0.52
1.4
1.2
—
—
—
0
0
17
127
1.35
0.50
2.9
3.6
3.87
4.18
e9/l
0.42
17
127
12
84
1.43
0.49
1.1
1.2
—
—
—
0
0
7
45
1.56
0.49
1.3
1.2
—
—
—
0
0
24
191
1.26
0.47
1.0
1.2
—
—
—
0
0
33
273
1.22
0.46
1.6
1.4
22.00
26.94
iu/l
0.31
28
230
16
209
0.76
0.45
1.5
1.5
—
—
—
0
0
79
708
1.13
0.43
1.7
1.5
—
—
—
0
0
24
294
0.81
0.42
1.7
1.6
—
—
—
0
0
0
17
0.00
0.40
0.0
2.2
—
17.55
—
0
17
11
147
0.74
0.37
2.1
1.6
—
—
—
0
0
9
69
1.31
0.37
2.7
2.3
—
—
—
0
0
41
359
1.15
0.34
6.5
4.6
36.94
36.91
°c
0.20
41
354
6
88
0.68
0.33
1.0
1.1
—
—
—
0
0
18
146
1.24
0.32
6.4
4.2
19.60
29.58
mg/l
1.34
12
107
52
465
1.13
0.32
1.3
1.3
—
—
—
0
0
12
154
0.78
0.32
1.4
1.3
—
—
—
0
0
15
120
1.25
0.30
2.1
2.3
—
—
—
0
0
19
157
1.22
0.29
2.7
3.4
57.35
58.70
%
0.28
19
157
19
225
0.84
0.26
13.6
10.4
—
—
—
0
0
11
88
1.25
0.22
1.3
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
22.60
—
0
5
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
65
607
1.08
0.20
1.4
1.4
—
—
—
0
0
12
99
1.22
0.19
1.4
2.0
30.50
32.54
pg
0.75
12
99
11
90
1.23
0.19
1.4
1.1
—
—
—
0
0
154
1597
0.96
0.18
3.1
3.3
0.82
0.77
ug/l
0.33
101
1047
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
8
69
1.16
0.16
1.5
1.4
—
—
—
0
0
101
967
1.05
0.16
1.3
1.3
—
—
—
0
0
6
77
0.78
0.15
1.5
1.5
—
—
—
0
0
6
80
0.75
0.15
1.7
1.6
—
—
—
0
0
9
80
1.13
0.15
1.3
1.8
—
—
—
0
0
23
252
0.91
0.13
1.7
1.9
38.48
39.93
nmol/l
0.14
23
242
10
115
0.87
0.10
1.2
1.1
—
—
—
0
0
10
115
0.87
0.10
1.2
1.1
—
—
—
0
0
34
319
1.07
0.10
1.0
1.1
—
—
—
0
0
17
154
1.11
0.10
3.6
4.5
2.20
2.65
mmol/l
0.44
12
105
10
87
1.15
0.09
1.1
1.3
—
—
—
0
0
7
64
1.09
0.08
1.3
1.2
—
—
—
0
0
9
104
0.86
0.06
1.3
1.7
—
—
—
0
0
66
677
0.97
0.05
2.5
2.4
12.77
13.41
nmol/l
0.24
59
626
32
308
1.04
0.04
2.0
1.7
0.34
0.33
mg/l
0.03
17
145
13
121
1.08
0.03
2.7
2.7
—
—
—
0
0
24
232
1.04
0.02
1.2
1.2
0.85
0.91
g/l
0.70
24
232
10
98
1.02
0.00
1.1
1.2
—
—
—
0
0
22
221
1.00
0.00
1.0
1.1
1.45
1.52
g/l
0.74
22
221
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
9.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
1.4
1.7
0.68
1.19
promille
—
5
48
5
59
0.85
-0.00
1.6
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_BCKRNDRETINOPAT and mortality.

Females

Parameter HR [95% CI] p-value
H7_BCKRNDRETINOPAT 1.398 [1.23, 1.59] < 0.001
Birth year 0.998 [0.99, 1.01] 0.678

During the follow-up period (1.1.1998 — 31.12.2019), 810 out of 2446 females with H7_BCKRNDRETINOPAT died.

Males

Parameter HR [95% CI] p-value
H7_BCKRNDRETINOPAT 1.353 [1.17, 1.56] < 0.001
Birth year 0.99 [0.98, 1.0] 0.037

During the follow-up period (1.1.1998 — 31.12.2019), 716 out of 2418 males with H7_BCKRNDRETINOPAT died.

Mortality risk

Mortality risk for people of age

years, who have H7_BCKRNDRETINOPAT.

N-year risk Females Males
1 0.149% 0.271%
5 0.836% 1.616%
10 2.152% 4.152%
15 4.438% 7.965%
20 7.889% 13.748%

Relationships between endpoints

↥

Index endpoint: H7_BCKRNDRETINOPAT – Background retinopathy and retinal vascular changes

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data